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ABSTRACT 
 
Consumption of polyphenol-rich foods, such as berries, fruits, tea and cocoa has been 
claimed to exert beneficial effects on cardiovascular health. Wild Nordic berries, e.g. 
lingonberry (Vaccinium vitis-idaea), bilberry (Vaccinium myrtillus), cranberry (Vaccinium 
oxycoccos, V. microcarpum) and cultivated blackcurrant (Ribes nigrum) are good sources of 
polyphenols including flavonoids, such as anthocyanidins, proanthocyanidins and flavonols. 
The aim of this series of studies was to investigate the effects of cranberry, lingonberry and 
blackcurrant juices on vascular function of genetically hypertensive rats and to clarify how 
lingonberry affects the blood pressure of spontaneously hypertensive rats and normotensive 
rats consuming a high-salt diet. We also wanted to determine whether lingonberry juice 
could exert effects on low-grade inflammation, a phenomenon, which has been related to 
hypertension and excess salt intake. 
The established high blood pressure of spontaneously hypertensive rats became lowered 
during an eight-week treatment with lingonberry juice. However, more concentrated 
lingonberry juice was unable to prevent the development of genetic hypertension in young 
rats. Nonetheless, the endothelium-dependent relaxation of mesenteric arteries was 
enhanced after eight weeks’ treatment with the more concentrated lingonberry juice as was 
also the endothelium-independent relaxation.  
Positive effects of lingonberry juice on inflammatory markers were observed in both rat 
models. After lingonberry juice treatment, serum levels of both angiotensin II and alkaline 
phosphatase were lower than in the control groups. Possible anti-inflammatory and anti-
thrombotic effects were present due to the reduced gene expression of cyclooxygenase 2 
(COX2), monocyte chemoattractant protein 1, p-selectin and vascular cell adhesion molecule 
1. These results indicate that inhibition of the renin-angiotensin system together with 
enhanced nitric oxide production could be possible mechanisms behind the positive effects 
on blood pressure and vascular function. The lingonberry treatment lowered gene 
expression of COX2 in the aorta, and increased COX2 protein expression in the kidney cortex 
macula densa, possibly indicating that inducible COX2 had been inhibited whereas the 
important constitutive COX2 was maintained by lingonberry treatment. Molecular docking 
studies conducted with flavonoid structures indicated that kaempferol may exert inhibitory 
effects on COX2.  
In summary, in an experimental model of hypertension, long-term treatment with 
lingonberry juice was able to lower blood pressure and improve vascular function. The 
effects on RAS and possible ACE1 inhibition together with enhanced nitric oxide 
bioavailability are potential mechanisms involved in these positive cardiovascular effects. 
Furthermore, lingonberry possesses anti-inflammatory properties, which may well contribute 
to its ability to reduce blood pressure and improve vascular function. 
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1 INTRODUCTION 
 
Cardiovascular diseases are a major cause of death all around the world  (Benjamin et al. 
2018). Almost every second Finnish man and every third woman suffer from increased blood 
pressure. During recent years, the levels of Finnish adults’ diastolic blood pressure (DBP) 
have started to increase, whereas systolic blood pressure (SBP) has slightly declined. The 
causes behind the increased DBP values have been suggested to be alcohol, obesity and 
excess salt intake (Laatikainen et al. 2012).  
 
The deterioration of vascular function is one of the first findings in cardiovascular disease 
and this phenomenon has been linked with hypertension, smoking, hyperlipidemia or 
diabetes, all of which contribute to premature vascular aging (Guzik and Touyz 2017). 
Recently, hypertension and vascular dysfunction have been regarded as consequences of 
inflammatory pathophysiological processes. It has also been postulated that hypertension is 
a consequence of an imbalance in body homeostasis, a disturbance in important endogenous 
systems and subsequent physiological errors. The renin-angiotensin system and the kidneys 
play a major role in the regulation of blood pressure in conjunction with neuronal and 
hormonal mechanisms.  
 
In addition to medication, lifestyle guidance and consuming a healthy diet are important 
aspects of both the prevention and the treatment of cardiovascular diseases. A diet 
containing an abundance of polyphenol-rich berries, fruits and vegetables has been shown 
to improve cardiovascular health and to decrease the risk of mortality  (Rissanen et al. 2003; 
Jennings et al. 2012; Kimble et al. 2018). Most of the experimental and clinical studies have 
been conducted with fruits, tea and cocoa. However, wild Nordic berries, such as lingonberry 
(Vaccinium vitis-idaea), bilberry (Vaccinium myrtillus), cranberry (Vaccinium oxycoccos, V. 
microcarpum) and cultivated blackcurrant (Ribes nigrum) are excellent sources of 
polyphenols including flavonoids, such as anthocyanidins, proanthocyanidins and flavonols.    
 
The aims of this series of studies were to investigate the effects of cranberry, lingonberry 
and blackcurrant juices on the vascular function of genetically hypertensive rats. We also 
wanted to examine the effect of lingonberry juice on blood pressure and inflammatory status 
as measured with circulating and local vascular markers. We used a salt-loaded rat model to 
determine if lingonberry could exert effects on kidney function and inflammation. Finally, we 
examined the actions of the lingonberry juice on an important inflammatory and vasoactive 
mediator, cyclooxygenase 2 (COX2).     
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2 REVIEW OF THE LITERATURE 
 
2.1 Regulation of blood pressure  
Blood pressure is the hydrostatic pressure in the circulatory system. Two parameters, 1) total 
peripheral resistance and 2) cardiac output, the latter representing the amount of blood 
pumped to the aorta in one minute, are responsible for the blood pressure. Blood pressure 
can be detected as systolic or diastolic blood pressure, diastolic being the period of relaxation 
and systolic representing the period of contraction. Long-term blood pressure is controlled 
by several mechanisms involving nerves, kidneys and vasculature.  
Vascular tone is controlled by neuronal, hormonal and other circulating agents, as well as by 
factors released from endothelium acting finally on vascular smooth muscle. Vascular 
function is a crucial physiological mechanism, where different cell types, receptors, enzymes, 
hormones, vasodilators and constrictors interact to maintain the balance and homeostasis 
of the body. Peripheral resistance and blood pressure are mainly determined by the 
conditions in the small arteries and networks, since flow resistance according to Poiseuille´s 
law is inversely proportional to the fourth power of blood vessel diameter. Thus, normal 
functioning of the arteries is essential for maintaining normal blood pressure. 
Aging, lifestyle habits and heredity all affect the development of the blood pressure. Excess 
consumption of alcohol and salt, being overweight and physically inactive as well as stress 
make an individual susceptible to becoming hypertensive. According to Finnish Current Care 
Guidelines, blood pressure is categorized as increased if SBP is over 140 mmHg and DBP over 
90 mmHg (Hypertension: Current Care Guidelines, 2014). However, in the USA, these 
categories have been changed in recent years and blood pressure is considered elevated, if 
SBP exceeds 120 mmHg and DBP 80 mmHg  (Whelton et al. 2018). Hypertension exposes the 
individual to serious risks e.g. to coronary artery disease and stroke. The presence of high 
cholesterol levels, metabolic disorder, insulin resistance and renal dysfunction commonly co-
exist with hypertension. Untreated hypertension is a major “silent” risk for death. 
Blood pressure is mainly regulated by the sympathetic (adrenergic) nervous system, kidney 
and body fluid homeostasis. The parasympathetic (cholinergic) nervous system makes a 
contribution by regulating heart function. Long-term blood pressure is regulated through the 
kidneys, the Renin-Angiotensin-System (RAS) and the Kallikrein-Kinin-System (KKS).  
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2.1.1 Sympathetic nervous system 
The sympathetic nervous system is responsible for the rapid changes taking place in blood 
pressure, whereas central nervous system controls the level over longer periods (6-8 h). The 
vasomotor centre in the brain medulla maintains the appropriate tonus of arteries and 
regulates the heart rate via parasympathetic signals transmitted through the vagal nerve. 
The sympathetic nerves innervate organs and blood vessels, except the capillaries. An 
elevated activity of sympathetic nerves in kidneys increases renal vascular resistance, 
triggers renin release and promotes tubular sodium reabsorption, all of which contribute to 
the retention of sodium and water, inducing an increase in arterial pressure. (Hall and 
Guyton 2011a) 
 
 
Baroreceptor reflex 
 
The sympathetic barosensitive neurofibrils are regulated by baroreceptors and stimulation 
of baroreceptors transmits a signal that is received by the central nervous system from 
where it is then transferred to the autonomic nervous system. This baroreceptor reflex aims 
to stabilize blood pressure by adjusting the vascular diameter and heart function but 
persistent hypertension diminishes its sensitivity. Baroreceptors are typically located in the 
carotid sinus and aortic arch, although a few receptors are also present in other large 
arteries. Neurons in the tractus solitarius in the central nervous system receive the signal 
transmitted by baroreceptors through glossopharyngeal and vagus nerves and deliver the 
information to the sympathetic and parasympathetic centers in the brainstem. Signalling in 
tractus solitarius then triggers an inhibition of the vasoconstrictor signals as well as an 
activation of the parasympathetic center to dilate the arteries, decrease heart rate and to 
reduce the strength of cardiac contraction.  (Guyenet 2006; Lohmeier and Iliescu 2015) 
 
The baroreflex affects the long-term control of blood pressure and it appears to 
communicate also with renin-angiotensin-aldosterone system (RAAS). The potent 
vasoconstrictive agent, angiotensin II (Ang II), has detrimental effects on the autonomic 
nervous system and baroreceptor reflex. For instance, angiotensin II causes a sympathetic 
neural discharge and increases the density of sympathetic innervation. Furthermore, the 
activity in the arterial baroreceptor reflex is reduced when baroreceptors in the aortic arch 
and vagal nerve firing are inhibited by angiotensin II. Vasoconstriction mediated via the α1 
adrenergic receptor is increased as the response to noradrenaline is enhanced.  Angiotensin 
1-7 (Ang 1-7), a newly found component of RAS seems to have opposite effects on the 
autonomic nervous system, e.g. arterial baroreceptor function improves whereas discharges 
from the sympathetic nerves decrease. Furthermore, Ang1-7 has direct vasodilatory effects 
via Mas-receptors.  (Miller and Arnold 2018) 
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Alpha- and beta-adrenergic regulation  
 
The catecholamines, adrenaline and noradrenaline, as well as their precursor dopamine are 
the most important neurotransmitters in the sympathetic nervous system. Adrenaline is 
secreted from the adrenal gland whereas noradrenaline is mainly released from sympathetic 
nerve endings. Vasoconstriction occurs when noradrenaline is released from nerve endings 
into the synaptic cleft. Catecholamine signalling is transduced through G-protein coupled α- 
and β-adrenergic receptors. Stimulation of α- and β-adrenergic receptors activates inhibitory 
or excitatory effects, depending on the organs in which they are situated. For example, α-
adrenergic receptors induce vasoconstriction in the arteries, but relaxation in the intestine. 
(Hall and Guyton 2011 b) In the vascular smooth muscle, α-receptor subtypes (α1 and α2) 
mediate vasoconstriction. The predominant postsynaptic subtype depends on the vascular 
site, diameter and the individual (Langer and Hicks 1984). Stimulation of β-receptors causes 
a dilatation of vascular smooth muscle and endothelium-derived vasoactive agents regulate 
vascular tone locally. It seems that the role of nitric oxide (NO) in β-mediated vasorelaxation 
is highly dependent on the vascular area and size of the artery  (Priest et al. 1997). For 
example, mesenteric resistance arteries are relaxed by NO after stimulation of β1-
adrenoreceptor in rats (Graves and Poston 1993). Beta-adrenergic receptors regulate renin 
secretion from juxtaglomerular cells in kidneys. The renin-angiotensin system and 
sympathetic nervous system act in parallel to regulate blood pressure. The sympathetic 
nervous system also controls to some extent sodium reabsorption in the renal tubules.  
(Wehrwein and Joyner 2013)  
 
2.1.2 Renin-angiotensin system  
Indications of renin-angiotensin system (RAS) were initially discovered by the Finnish 
physiologist Robert Tigerstedt in collaboration with Per Bergman in 1898 when they detected 
the presence of renin in kidney lysate  (Tigerstedt and Bergman 1898). However, it was 
almost a century later before the importance of RAS in blood pressure control and fluid 
homeostasis was understood  (Peart 1975). Today, it is known that RAS is an endocrine, 
paracrine and intracrine system, which is involved in several crucial processes in the body. 
Traditionally, RAS is known to regulate blood pressure, but it also contributes to 
inflammatory response, oxidative stress and cognitive function. A local RAS has been found 
in several organs; heart, arteries, kidneys, adrenal glands, brain, intestine, adipose tissue and 
eye. The RAS includes several angiotensin peptides and peptidases and at least six receptors. 
The Angiotensin converting enzyme 1 (ACE1) – Angiotensin II – AT-1R route is involved in 
vasoconstriction, cell differentiation, regulation of fluid homeostasis and fibrosis. 
Conversely, Angiotensin converting enzyme 2 (ACE2) – Angiotensin 1-7 – Mas-receptor 
(MasR) axis acts in an antagonistic fashion to inhibit the effects of angiotensin II.  (Fyhrquist 
and Saijonmaa 2008) Even intraocular pressure is partly regulated by RAS  (Holappa et al. 
2017). Figure 1 illustrates the most important RAS pathways.  
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Figure 1. Simplified illustration of renin-angiotensin system and kallikrein-kinin system. 
RR=(pro)renin receptor, t-PA=tissue-type plasminogen activator, NEP=neutral endopeptidase, 
POP=prolyl oligopeptidase. Des-Arg-Bra=des-Arg-bradykinin. Modified from Siltari 2018 with 
permission.  
 
 
Angiotensin I (Ang I), a weak vasoconstrictor itself, is cleaved to angiotensin II (Ang II), one 
of the most powerful vasoconstrictors in the body, by ACE1. Angiotensinogen is the only 
precursor for all angiotensin peptides, but its actions are complex. Renin cleaves 10 N-
terminal amino acids to produce Ang I from which other angiotensin peptides are formed. 
This cleavage is the rate-limiting step and the efficacy can be alleviated by domain 
interactions occurring behind the N-terminal amino acids  (Streatfeild-James et al. 1998).  
 
 
Renin and (pro)renin 
 
Renin and its precursor prorenin are produced in the kidneys. Renin is an enzyme which 
breaks down angiotensinogen (from liver) into Ang I. Prorenin is secreted from the 
juxtaglomerular cells in the nearby renal glomerulus and is activated by cathepsin β or the 
proconvertase enzyme in a response to a reduction in blood pressure, lowered sodium 
balance or activation of central nervous system  (Davis and Freeman 1976; Kurtz 2011). The 
releases of renin and prorenin are mediated by (pro)renin-receptor (PRR)  (Nguyen et al. 
2002). Renin and prorenin can act as vasoconstrictors via PRR. When prorenin binds to PRR, 
this stimulates intracellular signalling cascades controlling cell proliferation, cycle, survival 
and angiogenesis. Angiotensinogen cleavage is markedly enhanced when prorenin is bound 
to PRR expressing membranes; it is a potent form of angiotensin II -independent signalling.  
(Peters 2017).  
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The kidney (the juxtaglomerular apparatus) is the main regulator of renin secretion under 
normal conditions. Renin can be produced also in mast-cells and macrophages. Intracellular 
calcium and cyclic adenosine monophosphate (cAMP), prostacyclin (PGI2) and prostaglandin 
E2 (PGE2) are all able to stimulate renin release. cAMP activity is inhibited by Ang II and 
calcium-signalling pathway I in renin-producing cells which have been appropriately 
stimulated  (Kurtz and Penner 1989; Edwards and Stack 1993; Kurtz 2011).  
 
 
ACE1 
 
Carboxypeptidase angiotensin convertase enzyme 1 (ACE1) converts angiotensin I into 
angiotensin II by cleavage of two amino acids from the peptide’s C-terminal end. Various 
epithelial cells, e.g. proximal tubule epithelium, intestinal epithelium, endothelium and lung 
capillary cells express ACE1  (Bruneval et al. 1986; Culver et al. 2017). Somatic ACE1 is a 
polypeptide with two homologous active sites, N and C  (Soubrier et al. 1988). ACE1 is not 
specific for Ang I; it also breaks down other peptides and proteins, such as bradykinin, 
encephalin, neurotensin and cholecystokinin. The structure of ACE1 is homologous to the 
bradykinin metabolizing kininase II in the kallikrein-kinin system  (Rahimi 2016). Circulating 
ACE1 is synthetized prominently in lungs, but local production of ACE1 in the kidneys is even 
five times greater. The levels of kidney ACE1 are significantly increased in several blood 
pressure and kidney injury models.  (Culver et al. 2017)  
 
 
Angiotensin II 
 
Angiotensin II is one of the most powerful physiological vasoconstrictors. It is an octapeptide 
formed by cleavage of angiotensin I by ACE1 or other enzymes, such as cathepsin G, 
kallikrein, tonin and chymase. The actions of Ang II are mediated via counteracting AT1- and 
AT2- receptors (Figure 1). Binding to AT1R stimulates intracellular pathways; calcium 
channels, NADPH oxidases (NOx) and MAP kinases evoking vasoconstriction, inflammation 
and fibrosis. The formations of reactive oxygen species and several oxidases i.e.  NOx 1, 2, 4 
and 5, are stimulated by Ang II. Ang II promotes inflammation by accelerating reactive oxygen 
species (ROS) production, and increasing the production of cytokines, adhesion molecules 
and redox-sensitive inflammatory genes.  (Montezano et al. 2014) Small peptides are cleaved 
from Ang II, some having vasodilatory and some with vasoconstrictive effects. Ang 1-7 and 
its close relative alamandine are able to counteract Ang II by acting through the sympathetic 
nervous system, and inhibiting the baroreflex and inflammation. Ang 1-7 acts through MasR, 
mediating NO production by inhibition of MAP-kinases, activation of protein tyrosine 
phosphatase and inactivating the ROS formed by NOx  (Montezano et al. 2014; Miller and 
Arnold 2018) . 
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ACE2 
 
ACE2, an isoenzyme for ACE1, was first described by Donoghue et al. (2000). ACE2 acts as a 
carboxypeptidase and metalloproteinase  (Hooper and Turner 2003). ACE2 has highest 
affinity for Ang II, but it also hydrolyses other small angiotensin peptides. ACE2 activity is 
down-regulated in pathological states, such as hypertension and renal disorders  
(Montezano et al. 2014). ACE2 is mainly expressed in the heart, endothelium, testes and 
kidneys  (Donoghue et al. 2000), but it has been detected also in other tissues, like intestine, 
lungs and liver  (Tipnis et al. 2000; Hamming et al. 2004). Interestingly, as well as peptidase 
activity, ACE2 is a receptor for the SARS coronavirus, but it also protects lungs from lethal 
lung failure in SARS  (Kuba et al. 2010).  
 
 
2.1.3 Kallikrein-kinin system  
The kallikrein-kinin system (KKS) participates in blood pressure regulation in addition to RAS. 
Kinins (bradykinin, kallidin and methionyl-lysyl-bradykinin) are physiologically and 
pharmacologically active polypeptides, which are released by kallikrein enzymes from body 
fluids and tissues. Bradykinin was first detected in a snake venom by Rocha and Silva in 1949, 
when they observed the venom’s blood pressure lowering effect. In many respects, KKS 
functions as a compensatory system to RAS. It causes vasodilatation, regulates sodium 
excretion and reduces total peripheral resistance. Endothelium-dependent relaxation is 
enhanced by bradykinin and mediated by NO, endothelium-dependent hyperpolarizing 
factor (EDHF) and prostacyclin via several mechanisms (Ohlmann et al. 1997). Arterial 
smooth muscle tone is maintained by bradykinin and other kinins. The actions of kinins are 
mediated by bradykinin-receptors (BR1 and BR2) which are receptors that are produced as 
needed locally from the endothelial surface  (Duka et al. 2006). The bradykinin receptors 
have different roles, with BR1 being more evident in pathophysiological conditions.  It has 
been reported that BR2 expression is decreased in the left ventricles of patients with end 
state heart failure  (Kuoppala et al. 2002).  In contrast, Liesmaa et al.  (2005) found that in 
the endothelium of coronary arteries, BR1 receptors were overexpressed in patients with 
coronary artery disease and idiopathic dilated cardiomyopathy. ACE inhibitors have shown 
to potentiate the effects of bradykinin on endothelium-dependent relaxation in bovine and 
human arteries  (Auch-Schwelk et al. 1993). Inflammation, chemical and physical stressors 
activate circulating kallikrein and bradykinin. It has been demonstrated that the actions of 
bradykinin are dependent on age  (Mantelli et al. 1995; Siltari et al. 2016). For example, Siltari 
et al. (2017) found that in old spontaneously hypertensive rats (SHR), bradykinin is even 
vasoconstrictive, an effect proposed to be due to vascular inflammation and dysfunction. 
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2.1.4 Kidneys as a regulator of blood pressure 
The kidneys are an important regulator of blood pressure and body fluid and electrolyte 
homeostasis, as well as excreting metabolites and xenobiotics. Several hormones are 
secreted and metabolized in the kidneys. The kidneys regulate blood pressure through two 
different mechanisms: 1) Sodium ion and water excretion (pressure natriuresis) and 2) Renal 
RAS.  
 
 
Pressure natriuresis  
 
Extracellular sodium and water concentrations regulate the extracellular fluid volume and 
urine excretion. Guyton et al.  (1972) were the first to hypothesize that the kidney controls 
extracellular fluid volume as a way of regulating the blood pressure. Changes in blood volume 
and cardiac output affect renal perfusion pressure. In other words, an increase in arterial 
blood pressure results in increased excretion of sodium and water in urine. In normal 
situations, the pressure natriuresis feedback system is stable and blood pressure does not 
change extensively even if short term sodium intake is high, but long-term excessive salt 
intake leads to kidney stress and an increase in blood pressure. The excretions of water and 
electrolytes are stringently mediated by glomerular filtration, tubular reabsorption and 
secretion. There are several active agents capable of changing medullary blood flow and 
pressure natriuresis e.g. NO, hemoxygenase and the prostaglandins produced by 
cyclooxygenases. These vasodilators are antagonistic to the vasoconstrictive Ang II and 
endothelin, as well as to reactive radicals like O2- and H2O2.  (Taal et al. 2011; Ivy and Bailey 
2014) 
 
 
Kidney RAS and aldosterone  
 
Circulating renin and Ang II enable the blood pressure to remain unchanged independently 
of sodium intake. Renin release is continuously controlled; the feedback control is 
maintained by baroreceptors, sympathetic nerves and chloride-sensitive receptors.  (Taal et 
al. 2011)  
 
Sodium reabsorption results in increased blood pressure due to increased extracellular 
volume. Furthermore, there is elevated sensitivity to the actions of Ang II and other 
vasoconstrictive agents. In addition, Ang II stimulates prostaglandin and cyclic adenosine 
monophosphate (cAMP) production in order to reduce calcium intake.  (Taal et al. 2011) 
Disturbances in intrarenal RAS are important contributors to the pathophysiology of 
hypertension and renal disease  (Kobori et al. 2007; Yang and Xu 2017).  
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The endothelium in the glomerular arterioles, mesangial cells and distal nephrons express 
ACE1. The enzyme is also expressed in proximal tubules, especially in the brush border of the 
tubule  (Casarini et al. 1997). Peripheral vascular resistance is increased due to direct 
vasoconstrictive effects, sodium reabsorption is accelerated and the secretion of 
aldosterone is enhanced.  (Culver et al. 2017) 
 
Aldosterone, a component of renin-angiotensin-aldosterone system (RAAS), is a 
mineralocorticoid secreted from adrenal cortex. Its main function is to regulate extracellular 
fluid volume by transporting ions through epithelium. Aldosterone causes a concentration 
dependent endothelial dysfunction and it has been shown also to be associated with 
hypertension. Aldosterone has several actions: it accelerates inflammation by promoting the 
excretion of histamine from macrophages, it induces vascular remodelling (especially with 
salt) and stimulates ROS. NO availability is lowered due to aldosterone activation of sodium 
channels.  (Briet and Schiffrin 2013; Vanhoutte et al. 2017)  
 
 
Tubuloglomerular feedback and vasoactive agents in glomeruli 
  
Nephron is the functional unit, where glomeruli and tubules act to filter primary urine from 
blood. In the glomerulus, primary urine, containing water and electrolytes but not proteins, 
is filtered. The capillary endothelium surrounding glomerulus expresses inducible (iNOS) and 
endothelial NO synthase (eNOS)  (Bachmann et al. 1995; Furusu et al. 1998) and produces 
vasoactive agents such as nitric oxide (NO) and endothelin 1 (ET1)  (Jourde-Chiche et al. 
2019). The juxtaglomerular apparatus next to the glomeruli produces renin and Ang II. 
Macula densa (MD) in the juxtaglomerular apparatus is an important site for regulation of 
renin release e.g. in response to the concentration of chloride in tubular fluid together with 
a contraction of afferent arterioles. Prostacyclin is released from macula densa in states with 
low tubule fluid chloride concentrations whereas ATP is released when the chloride 
concentration is high. (Kurtz 2011) Tubuloglomerular feedback regulates the glomerular 
filtration rate via the glomerular arterioles. Initiation of renin expression starts when sodium- 
and chloride concentration changes are detected by macula densa cells  (Taal et al. 2011). 
The level of renin expression parallels the expression levels of nNOS and COX2 in macula 
densa cells as evidence for a connection between renin expression, COX2 and nNOS derived 
NO  (Harris et al. 1994; Harris and Breyer 2001; Harris et al. 2004).  
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To summarize, blood pressure is controlled by several mechanisms and systems acting 
in harmony with each other. The sympathetic nervous system, acting via baroreceptor 
reflex and α- and β-adrenergic receptors, is generally responsible of rapid blood 
pressure control. The renin-angiotensin system (RAS), kallikrein-kinin system and 
kidneys are the main regulators of long-term blood pressure and fluid homeostasis. 
The components of RAS include vasodilatory and vasoconstrictive agents, such as 
angiotensin II and angiotensin 1-7 together with their receptors AT1R, AT2R and Mas. 
Angiotensin II is a powerful vasoconstrictor and it mediates its effects also through 
inflammatory and oxidative pathways. The kidneys regulate blood pressure mainly by 
pressure natriuresis and local RAS. Aldosterone secretion from adrenal cortex is 
associated with RAS and is an important physiological regulator of electrolyte (Na+, K+) 
excretion in the kidneys.  
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2.2 Vascular function  
2.2.1 Arterial structure  
 
Blood vessels consist of three different layers; tunica intima, tunica media and tunica 
adventitia (Figure 2). These layers are further divided into different layers. Tunica adventitia 
contains connective tissue, small blood vessels (vasa vasorum) and nerves (nervi vasorum). 
Connective tissue is a complex of differently orientated collagen fibres, fibroblasts and elastic 
fibres. Witter et al. (2017) postulated that tunica adventitia in fact consists of two parts: 
tunica externa, the compact connective tissue layer and tunica adventitia, a loose connective 
tissue layer which is the outermost part of the vessel. Tunica media consists mainly of 
vascular smooth muscle cells (VSMC), but there are also some collagen fibres, elastic fibres 
and proteoglycans secreted by VSMC. The innermost part of the vessel, tunica intima, is 
basically formed of endothelial cells and elastic basal lamina, which separates endothelial 
cells from the vascular smooth muscle cells. According to current knowledge, tunica 
adventitia has an important role in vessel function. Vascular superoxide production, 
oxidative stress and vascular remodelling in vascular pathophysiology states seem to occur 
in adventitia  (Wang et al. 1998; An et al. 2007). Vessel diameter, or smooth muscle cell 
function, are modulated by vasoactive agents as well as by the ROS secreted by the 
endothelial cells (Figure 3).  
 
 
Arterial smooth muscle  
 
In healthy arteries, smooth muscle cells (SMC) are organized within medial layers in 
electrically coupled aggregates. The highly plastic and multifunctional nature of SMC enables 
both vasodilatory and vasoconstrictive actions, which are important in the control of vascular 
tone and pressure. Dedifferentiation of smooth muscle cells can be triggered by shear stress 
as well as by the presence of growth factors and cytokines produced by endothelium. In the 
pathogenesis of vascular disease, dedifferentiation can lead to the smooth muscle cells 
adopting a migratory and proliferatory phenotype. (Majesky 2016) Phenotype transitions are 
also possible via Ang II and transcription factors.  The consequences of this phenomenon 
include vascular hypertrophy and the release of vasoconstrictive, inflammatory factors into 
the vasculature. (Montezano et al. 2014)  
 
Vascular diameter is controlled in vascular smooth muscle by phosphorylation and de-
phosphorylation of contractile proteins. The Ca2+ concentration and calcium signalling are 
the most important regulators of vascular smooth muscle contraction. Noradrenaline, Ang 
II, endothelin 1 (ET1), thromboxane A2 (TXA2) together with membrane depolarization or 
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other chemical or mechanical stimulants can also cause the contraction of VSM. Calcium 
channels in VSM regulate calcium influx and efflux. (Touyz et al. 2018) 
 
The membrane potential of the VSMCs controls the vascular tone via potassium ion (K+) 
channel activity and the equilibrium between internal and external K+ concentrations. The 
opening of K+ channels and the efflux of K+ trigger a membrane hyperpolarization in vascular 
smooth muscle. Closing of voltage-dependent Ca2+ channels and reduced Ca2+ entry follow 
and vasodilatation occurs. There are known to be five different types of K+ channels in 
VSMCs: voltage-dependent K+ channels (KV ), Ca2+ -activated K+ channels (BKCa ), ATP-
sensitive K+ channels (KATP ), tandem two-pore K+ channels (K2 P) and inward rectifier K+ 
channels (Kir) (Dogan et al. 2019). The function of the channels and their activation 
mechanisms are not yet fully understood.  
 
 
 
 
Figure 2. Structure of the blood vessel. 
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Arterial endothelium 
 
The circulatory system is lined with vascular endothelium  (Fishman 1982). In arteries, such 
as the coronary artery, the innermost layer contains endothelial cells and elastic basal 
lamina. Endothelium is essential in maintaining circulatory health. Endothelium plays a role 
as an elastic and permeable barrier between the intravascular and extravascular systems. 
Macromolecules are transported via vascular smooth muscle and lumen. Endothelial cells 
form a semipermeable barrier through which macromolecules can cross with different 
mechanisms, most extensively via vesicular transport or through intracellular junctions 
between cells or with the help of vesicle fusion. (Ogunrinade et al. 2002) Vascular endothelial 
permeability is mostly regulated by vascular endothelial growth factors (VEGFs) and NOS  
(Tilton et al. 1999). Together with the adrenergic nerves and vasoactive substances, vascular 
function is locally regulated by endothelial cells secreting vasodilatory and vasoconstrictive 
substances. 
 
Shear stress caused by circulating blood is an important effector of endothelial permeability  
(Tarbell 2010). Shear stress affects mainly the endothelial cells, due to its tangential force, 
whereas cyclic strain modulates the activities also of the other parts of the vascular wall. 
Several vasoactive substances are released from endothelial cells in response to changes in 
hemodynamics. Vasodilatation usually is stimulated by increased shear stress and 
modulated via eNOS activity and NO production, whereas the vasoconstrictor, endothelin-1, 
tends to be released in states of low shear stress. There is also increased formation by COX1 
of the vasodilatory prostanoid, prostacyclin.  (Cahill and Redmond 2016)  
 
 
2.2.2 Vasoactive factors released from endothelium 
 
Several stimuli, like circulating hormones (catecholamines, melanocortin, vasopressin), 
autacoids (histamine, bradykinin, prostacyclin, prostaglandin E2), cytokines, drugs, 
chemicals or physical forces stimulate the endothelial cells to produce and release vasoactive 
agents that modulate vascular relaxation, contraction and permeability (Figure 3). Vascular 
relaxing factors include NO, prostacyclin, epoxyeicosatrienoic acid, adenosine and C-type 
natriuretic peptide. Vascular contracting factors are endothelin 1 (ET-1), thromboxane A2, 
isoprostanes, superoxide anion and Ang II. (Vanhoutte et al. 2017) 
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Figure 3. Vasoactive factors released from endothelium and smooth muscle cells during vascular 
constriction (A) and relaxation (B). Modified from Siltari 2018 with permission. 
 
 
Nitric oxide 
 
The most important vasodilating substance secreted by endothelial cells is nitric oxide (NO). 
Furchgott and Zawadzki in 1980 were the first to understand its mechanism. At that time, 
NO was called endothelium-derived relaxing factor (EDRF). NO/EDRF was identified 
chemically in 1987 by several researchers  (Ignarro et al. 1987; Palmer et al. 1987).  NO is 
synthetized from L-arginine and oxygen with the help of nitric oxide synthase (NOS) 
stimulated by chemical and physical stressors. The half-life of gaseous NO is only 6 seconds, 
so its effects in tissues are strictly local.  There are three types of NOS: endothelial (eNOS) 
and neuronal (nNOS) as well as inducible NOS (iNOS). eNOS is the main regulator of NO in 
the vasculature and its activation can occur in either a Ca2+ -dependent or –independent 
manner. An imbalance in normal electron flow of eNOS (uncoupling) and a lack of L-arginine 
or/and (6R-)5,6,7,8-tetrahydrobiopterin (BH4) change the normal NO production into the 
production of superoxide (O2-), and also ONOO-, which is formed when NO and O2- react  
(Moncada and Higgs 2006; Monica et al. 2016). Its second messenger, cyclic guanosine 
monophosphate (cGMP), is formed when intracellular enzyme soluble guanylate cyclase 
(sGC) converts guanosine triphosphate (GTP) to cGMP under stimulation of NO leading to 
activation of vasodilating cGMP protein kinase  (Ignarro et al. 1986). Antithrombotic and anti-
atherogenic action in the vasculature can be mediated by NO-sGC signaling but also by COX1 
– prostacyclin pathway  (Murad 1986; Marcondes et al. 2006). A lowered NO level is 
associated with an increase in platelet aggregation, the contraction and proliferation of 
smooth muscle, increased expression of adhesion molecules, LDL oxidation and monocyte 
and platelet adhesion. It is known that cGMP levels are lowered in hypertension and 
cardiovascular diseases. Diet and physical activity enhance the production of NO, but its level 
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are reduced by smoking or other oxidative stress states. It has been demonstrated that highly 
reactive superoxide anions are deleterious to NO.  (Monica et al. 2016).  In contrast, 
receptor-mediated agonists such as bradykinin stimulate the synthesis of NO via 
palmitoylation  (Robinson et al. 1995).  
 
 
Prostacyclin  
 
In addition to NO, the endothelium can synthetize the vasodilating prostanoid, prostacyclin 
(PGI2), which acts via cyclic adenosine monophosphate (cAMP) as the second messenger in 
smooth muscle cells  (Moncada and Vane 1978). John Vane received a Nobel Prize in 
Physiology or Medicine in 1982 for his studies into prostacyclin as well as clarifying the 
actions of non-steroidal anti-inflammatory drugs (NSAIDs). Prostacyclin is released from 
blood vessels in both normal and pathological conditions. For example, shear stress in vivo 
and acetylcholine in vitro stimulate the formation of prostacyclin. COX synthetizes 
prostacyclin from arachidonic acid and G-protein-coupled IP-receptors mediate the 
vasodilatory effects of prostacyclin. Its release from the endothelium of blood vessels is 
mainly determined by COX1  (Kirkby et al. 2013; Mitchell and Kirkby 2019). However, in cases 
with severe systemic inflammation, COX2 is the main producer of prostacyclin. The actions 
of prostacyclin are mainly mediated by two receptors, IP receptor and the cytosolic nuclear 
receptor PPAR β.  (Mitchell and Kirkby 2019) 
 
In summary, prostacyclin is a vasodilator, but it also possesses other effects. Prostacyclin 
inhibits platelet activation and rapidly dilates vessels, and over the long-term, it can affect 
gene transcription. In the kidneys, renin release from the juxtaglomerular apparatus is partly 
regulated by prostacyclin  (Patrono et al. 1982). Prostacyclin possesses also vasoconstrictive 
effects through the endoperoxides released from endothelium (Vanhoutte et al. 2017).  
 
 
EDHF 
 
Endothelium-derived hyperpolarizing factors (EDHF) are group of vasodilators, which cause 
vascular relaxation by hyperpolarizing the membrane potential of vascular smooth muscle 
cells by opening Ca2+-activated potassium channels. Shear stress, agonists (e.g. bradykinin 
and acetylcholine) and intracellular calcium regulate the release of EDHF. Blocking the 
release NO and/or the prostacyclin formation or their receptors cause compensatory 
mechanisms, which are thought to be due to EDHF. Endothelium-derived hydrogen peroxide 
(H2O2) has been proposed as one possible candidate of EDHF in humans and animals. 
However, H2O2 possesses a dual role, it is also able to induce COX-dependent thromboxane 
release and act as an ROS in pathological conditions, although this occurs at higher 
concentrations than needed for vasodilatation. There are other potential EDHFs e.g. 
potassium and epoxyeicosatrienoic acid. (Shimokawa 2010; Vanhoutte et al. 2017)  
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Endothelin 1  
 
Endothelin 1 (ET1) is one of the most potent physiological vasoconstrictor substances, 
initially described by Yanagisawa et al. (1988). Endothelial and vascular smooth muscle cells, 
leukocytes and macrophages synthesize endothelin 1. The vasoconstrictive actions of ET1 
are mediated through endothelin receptors. The release of ET1 is potently inhibited by NO. 
In pathological conditions, ET1 can be also proinflammatory and enhance the proliferation 
of smooth muscle cells.  (Vanhoutte et al. 2017) 
 
Endothelium-dependent vascular contraction occurs when vasoconstricting prostanoids are 
produced in the endothelium by COX. Aging, some diseases (hypertension, diabetes) or 
obesity all predispose the vascular smooth muscle cells to contract, but this can occur also 
in healthy and young subjects.  (Vanhoutte et al. 2017) Cyclooxygenases and thromboxane 
are discussed in Chapter 2.3.2.  
 
 
 
To summarize, the arterial wall consists of three layers, tunica intima, tunica media 
and tunica adventitia. Tunica adventitia has a major role in controlling vascular 
function, but the importance of the other layers in controlling vascular homeostasis is 
becoming more evident. Smooth muscle cells and endothelial cells control vascular 
viability and function. The vasoactive agents secreted by endothelial and smooth 
muscle cells can either increase or reduce the vessel diameter.  The actions of smooth 
muscle are contraction and dilation. The most important vasodilating factors are nitric 
oxide, prostacyclin, adenosine and natriuretic peptide. The most important 
vasoconstrictive factors include endothelin-1, thromboxane A2, isoprostanes, 
superoxide anion and angiotensin II. Vascular function is maintained by the balance 
between these factors. A fluid blood flow and shear stress contribute to vascular 
function.  
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2.3 Vascular inflammation and oxidative stress 
 
Vascular inflammation and oxidative stress are key mechanisms underpinning endothelial 
dysfunction and arterial damage. These states contribute to vascular aging and have been 
implicated in renal dysfunction, cardiac ischemia, cognitive decline as well macro- and 
microangiopathy.  (Guzik and Touyz 2017) 
 
2.3.1 Inflammatory response and NF-κB 
 
The inflammatory response is mediated by cytokines; of these, nuclear factor kappa B (NF-
κB) has a major role. Its activation stimulates the expression of other important cytokines, 
chemokines, adipokines, cell adhesion molecules and acute phase proteins. Both widely 
established and unconventional signalling pathways are associated with the activation of NF-
κB by different mechanisms. (Liu et al. 2017) 
 
Reactive oxygen species (ROS) are highly reactive radicals, which are formed in cellular 
redox-reactions. Free radicals are very reactive because they have an unpaired electron in 
their structure. Typically, they are released by inflammatory cells in times of inflammation. 
An increased amount of ROS attracts more inflammatory cells and this will intensify the 
effect. ROS act also as signalling molecules regulating vascular stiffness, structure and 
microcirculation. (Savoia and Schiffrin 2006) In the vasculature, free radicals are often 
formed via NAD(P)H-oxidases. Ang II can promote the formation of ROS via NOx. The 
superoxide anion (O2−) is a typical ROS and its effect on cardiovascular disease is widely 
recognized (Nguyen et al. 2013). The energy production by mitochondria is impaired by ROS 
via different mechanisms. This evokes imbalance of calcium homeostasis, ROS formation and 
modification in redox-signalling. (Sack et al. 2017)   
 
Angiotensin II has a major role in vascular inflammation in some tissues and organs, it 
stimulates the accumulation of monocytes and leucocytes in the subendothelial space of 
arteries increasing the production of adhesion molecules and chemotactic cytokines as well 
as inducing smooth muscle cell proliferation and platelet aggregation. In pathological 
conditions, such as hypertension and diabetes, it is recognized that vascular inflammation 
promotes atherogenic changes and lipid oxidation. (Montezano et al. 2014) Peroxisome 
proliferator activated receptors (PPAR) act as down-regulators of vascular inflammation, but 
Ang II inhibits PPARs through NF-kB activation  (Tham et al. 2002). 
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2.3.2 Prostanoids and COX enzymes  
 
Lipoxins, leukotrienes, hydroxy-eicosatetraenoic acids, eoxins, isoprostanes, resolvins and 
prostanoids are included in the eicosanoid family, formed by oxidation of ω3 or ω6 20-
carbon fatty acids. Eicosanoids and COX enzymes are widely distributed in the body and are 
important mediators and regulators of many processes, both for good and bad, including 
cardiovascular function and inflammation. In the vasculature, prostanoids are the most 
important eicosanoids.  (Mitchell and Kirkby 2019) Cyclooxygenase enzymes catalyze the 
oxidation of arachidonic acid (AA) released from membrane phospholipids by phospholipase 
A2 (PLA2) to prostanoids (Figure 4). Initially, prostaglandin G2 (PGG2) is formed by the 
oxidation of AA and further peroxidation yields prostaglandin H2 (PGH2), both being called 
also endoperoxides. Prostanoids are formed when specific synthases act on PGH2. 
Arachidonic acid release by PLA2 in blood vessels, is the rate limiting step in the prostanoid 
synthesis  (Kirkby et al. 2015). Different prostanoids have specific roles in mediating 
important body responses via different receptors e.g. mediating vasoconstriction, 
vasodilatation, uterine contraction and participating in allergic reactions. PGE2 acts on EP 1, 
2,3 and 4 receptors to trigger vasodilatation, proinflammation, natriuresis and pain. As 
discussed earlier, prostacyclin acts on IP-receptors regulating vasodilatation, inhibiting 
platelet aggregation and renin release. Thromboxane A2 evokes vasoconstriction, 
bronchoconstriction and platelet aggregation via TPα/β receptors.  (Ricciotti and Fitzgerald 
2011; Mitchell and Kirkby 2019). 
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Figure 4. Prostanoid synthesis. Modified from Ricciotti and Fitzgerald 2011. 
 
 
Two isoforms of cyclooxygenases exist, COX1 and COX2. COX1 was initially identified in 1977 
(Hemler and Lands 1977). COX2 was detected by three different groups using different 
methods in 1989 - 1991  (Rosen et al. 1989; Kujubu et al. 1991; Xie, W. L. et al. 1991). In 
general, COX1 is constitutively expressed, and COX2 is induced by inflammatory stimulus, 
like active transcription pathways NF-kβ, nuclear factor of activated T-cells (NFAT) and cAMP  
(Vane et al. 1998). Recently, constitutively expressed COX2 has also been found to be 
localized in different parts of the body, such as the kidneys, brain, lungs and thymus  
(Therland et al. 2004; Kirkby et al. 2013). COX2 has a crucial role in renal function and 
cardiovascular protection; it takes part in renal function and blood flow and is activated by 
NFAT in non-inflammatory conditions (Kirkby et al. 2018). Renin and sodium release, renal 
blood flow, blood pressure and renal homeostasis are all controlled by COX2. See (Harris 
2006). The importance of COX2 in renal function is evident since deletion of COX2 induces 
changes in over 1000 genes (Ahmetaj-Shala et al. 2015).  However, in the endothelium, COX1 
seems to be responsible for prostacyclin formation, although in cases with low yields of 
arachidonic acid, COX2 may be important because it has higher affinity for AA which means 
it can cause activation when there are lower levels of AA present.  (Mitchell and Kirkby 2019) 
In mouse arteries and in the aorta of SHR and diabetic rats, COX1 is upregulated leading to 
an enhancement of the vasoconstrictive prostanoid production in the endothelium and 
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contraction of vascular smooth muscle. COX2 upregulation has been demonstrated in times 
of oxidative stress as well as in patients with hypertension or diabetes  (Garcia-Cohen et al. 
2000; Shi and Vanhoutte 2008). Up-regulation of COX2 was seen also in coronary arteries of 
patients with diabetes (Szerafin et al. 2006). Inducible COX2 is present during pain, 
inflammation and fever, and furthermore in cancer, it evokes proliferation, angiogenesis and 
metastasis of the cancer cells. (Mitchell and Kirkby 2019) 
 
In the kidneys, COX2 regulates renal function and blood flow mediated by NFAT. COX2 is 
expressed in macula densa, cortical thick ascending limb and medullary interstitial cells. Its 
expression seems to be affected by medullary tonicity, growth factors, water and salt intake, 
adrenal steroids and cytokines. The collecting ducts seem to be the predominant expression 
site of COX1.  (Breyer and Harris 2001)  
 
Non-steroidal anti-inflammatory drugs (NSAID) are mostly non-selective, inhibiting both 
COX1 and COX2 although the newest agents are COX2 selective. NSAIDs block prostaglandin 
synthesis by competing with AA for binding to the catalytic site of cyclooxygenase, thus 
accounting for their anti-inflammatory actions. At the same time as evoking anti-
inflammatory actions, several other processes are also disturbed (Breyer et al. 2001). 
Selective COX2 antagonists have been developed; these drugs are often referred to as 
COXIBs. At first, the benefits of COXIBs were emphasized, since gastrointestinal 
ulcers/adverse effects were less common as compared to the old non-selective NSAIDs. 
Deleterious effects on renal balance caused by COXIBs were subsequently observed, 
including salt retention, hypertension, hyperkalemia, edema and acute renal failure. 
Interestingly, Ahmetaj-Shala et al.  (2015) found that the levels of the physiological 
endothelial nitric oxide synthase inhibitor, asymmetric dimethylarginine (ADMA), were 
significantly increased in mice and humans after administration of a selective COX2 inhibitor 
(celecoxib) as well as after treatment with a non-selective COX1/COX2 inhibitor (naproxen).   
 
2.3.3 CRP and alkaline phosphatase as diagnostic tools  
 
The levels of C-reactive protein (CRP) as well as those of other acute phase proteins are 
increased in blood in the long term follow-up in patients with increased blood pressure and 
blood cholesterol (Ridker et al. 2000). CRP (high sensitivity) is a marker for predicting the risk 
of cardiovascular diseases. The baseline level is around 3 mg/l, when it exceeds that value, 
the risk for CVD increases  (Blake et al. 2003). Cortez et al. (2016) described that in treatment-
resistant hypertensives, if CRP had increased over the median (3.8 mg/l), then this doubled 
the risk for the patient’s condition to deteriorate or for mortality due to CVD. 
 
Tissue nonspecific alkaline phosphatase (ALP) is highly expressed in liver and bone, and it is 
routinely measured in clinical practise. Interestingly, a linear association has been found 
between ALP and all-cause and cardiovascular mortality and myocardial infarction as well as 
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with coronary artery disease in older men (Tonelli et al. 2009; Park et al. 2013; 
Wannamethee et al. 2013). Furthermore, Perticone et al. (2015) showed that serum ALP 
values were inversely related to endothelium-dependent vasodilatation in uncomplicated 
and untreated essential hypertensive subjects.  In addition, the negative associations of ALP 
were attenuated if there was a relatively higher serum phosphorus level, even within the 
normal range. A positive and independent association between serum ALP level and 
inflammatory markers, CRP and leukocyte count, was found in adults aged 60 years or older  
(Seo et al. 2019). 
 
 
 
To summarize, vascular inflammation like in severe hypertension leads to 
arterial damage and endothelial dysfunction. Cytokines and reactive oxygen 
species are present in inflammatory states. Nuclear-factor κB is an important 
mediator of inflammation and it has a major role also in vascular inflammation 
acting through different pathways. Angiotensin II stimulates inflammation 
and the formation of ROS. Prostanoids are members of the eicosanoid-family. 
Different prostanoids have several physiological effects such as 
vasoconstriction, vasodilatation, inflammation, natriuresis and pain. 
Cyclooxygenase-enzymes exist in two isoforms, COX1 and COX2.  COX2 is 
mainly inducible and its levels are increased in inflammatory states. However, 
also constitutive COX2 exists and it has an important role in the regulation of 
renal function and blood flow. Non-steroidal anti-inflammatory drugs 
(NSAIDs) are inhibitors of cyclooxygenases. Serum C-reactive protein (hs-CRP) 
and alkaline phosphatase (ALP) can be used as diagnostic tools to monitor the 
extent of vascular inflammation and its associations with the incidence of 
cardiovascular diseases. 
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2.4 Hypertension and vascular dysfunction – pharmacological 
and dietary treatments 
 
Hypertension is a major risk factor for cardiovascular diseases and causes damage to several 
target organs, like left ventricle hypertrophy  (Kumpusalo et al. 2001), renal damage  (Rodicio 
et al. 1998), retinopathy (Ong et al. 2013) and arterial stiffness  (O'Rourke 1990).  The 
increased blood pressure stresses the heart and evokes vascular damage, which may 
contribute to heart attack and stroke (Kumpusalo et al. 2001). Target organ damage weakens 
the prognosis of hypertensive patients (Harbaoui et al. 2016). Even small changes in blood 
pressure matter, e.g. a 10-12 mmHg reduction of SBP and a 5 mmHg reduction of DBP lower 
the risk of stroke, coronary artery disease and all-cause mortality  (Benjamin et al. 2018). The 
classification of systolic and diastolic blood pressure levels and the diagnosis of hypertension 
as along with the recommendations for treatment according to Finnish Current Care 
Guidelines are presented in Table 1.  
 
A key feature of hypertension is early vascular aging, which includes remodelling and the 
premature development of vascular stiffness  (Guzik and Touyz 2017). Vascular stiffness and 
endothelial dysfunction disable normal vascular functioning and is often related to 
hypertension, arteriosclerosis and metabolic syndrome. Endothelial dysfunction is an 
important predictor of cardiovascular disease and one of the first steps on the route to 
atherosclerosis and coronary artery disease  (Vanhoutte et al. 2017). The protective role of 
endothelium is lost being replaced by a proatherosclerotic structure  (Vanhoutte 1989; 
2017). Reactive oxygen species, which are derivatives from oxygen metabolism, play a major 
role in vascular dysfunction. ROS counteract the effects of NO resulting in reduced NO 
bioavailability and the increased formation of peroxynitrite (ONOO-) (Incalza et al. 2018).  
The disturbed blood flow increases the reactions between NO and ROS and activates 
transcription factors (NF-KB), promoting the expression of monocyte chemoattractant 
protein 1 (MCP-1) and intracellular adhesion molecule 1 (ICAM-1), which are well known as 
pro-atherogenic agents.  (Hsieh et al. 2014) The development of lesions in atherosclerosis is 
affected by shear stress. Good vascular flow with a high shear stress seems to be 
atheroprotective, whereas low and oscillated flow in vessel segments promotes plaque 
formation  (Berk et al. 2002).  
 
Impaired NO bioavailability accelerates compensatory mechanisms and pathways. At first, 
endothelial-promoted vasodilatation remains almost normal due to the effects of 
prostacyclin and EDHF. Endothelial dysfunction and further vascular dysfunction are 
characterized also by the release of ET-1, TXA2, PGH2 and ROS. At some point, NO itself can 
contribute to vascular dysfunction by activation of soluble guanylate cyclase which promotes 
the production of cyclic inosine monophosphate instead of cGMP, which then causes a 
contraction of VSMC instead of their relaxation.  (Vanhoutte et al. 2017)  
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Table 1 Classification of blood pressure levels according to Finnish Current Care Guidelines 2014.  
Class SBP (mmHg) DBP (mmHg) Recommended actions 
Optimal <120 <80 Control measurement every 5 years 
 
Normal 120-129 80-84 Lifestyle guidance 
Control measurement every 2 years 
 
High normal 130-139 85-90 Lifestyle guidance  
BP levels re-evaluation in 4 months 
Home self-measurement or ambulatory 
measurement 
 
Mild 
hypertension 
140-159 91-99 Lifestyle guidance 
BP levels re-evaluation in 2 months  
Home self-measurement or ambulatory 
measurement 
 
Moderate 
hypertension 
160-179 100-109 Lifestyle guidance 
BP levels re-evaluation in 2 months  
Home self-measurement or ambulatory 
measurement 
 
Severe 
hypertension 
>180 >110 Lifestyle guidance 
BP levels re-evaluation in 1-2 weeks  
Home self-measurement or ambulatory 
measurement 
 
Hypertensive 
crisis 
 
>200 >130 Immediate treatment 
Isolated systolic 
hypertension 
>140 <90 Lifestyle guidance 
BP levels re-evaluation in 2 months  
Home self-measurement or ambulatory 
measurement 
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2.4.1 Pharmacological treatment of hypertension 
 
According to Finnish Current Care Guidelines, drug treatment is recommended, if systolic 
blood pressure is over 140 mmHg and diastolic 90 mmHg despite lifestyle modifications.   
The most common drugs used for hypertension are ACE-inhibitors, AT1 receptor antagonists, 
beta-blockers, thiazide diuretics and calcium antagonists depending on the patient and 
disease characteristics. Combinations of these drugs can be used, if monotherapy is not 
effective enough in lowering the patient’s blood pressure.  
 
The conversion of angiotensin I to angiotensin II is inhibited by ACE1-inhibitors (e.g. 
captopril, enalapril, ramipril), thus the formation of vasoconstrictive and proinflammatory 
Ang II is diminished. In addition, bradykinin breakdown is inhibited and serum aldosterone 
levels decreased. AT1R antagonists (candesartan, losartan, telmisartan) inhibit the actions of 
Ang II acting directly on the AT1R. Renin inhibitors (aliskiren) are rather new drugs acting at 
first steps of RAS-activation by inhibiting the formation of angiotensinogen. Calcium 
antagonists, like dihydropyridines, diltiazem and verapamil block the cellular entry of calcium 
through voltage-dependent L-type Ca-channels. Thiazide diuretics (e.g. hydrochlorothiazide, 
trichlormethiazide) and the thiazide-like agent (indapamide) inhibit the Na+/Cl- cotransporter 
in the kidneys. Beta-blockers act by blocking the beta1-receptors and are classified in three 
groups: non-selective beta-blockers e.g. propranolol and timolol (β1+β blocking), selective 
beta-blockers e.g. atenolol, bisoprolol, metoprolol (β1 blocking) and beta-blockers with 
supplemental effects e.g. carvedilol, nebivolol (with some peripheral vasodilating effects).  
(Williams et al. 2018) 
 
 
2.4.2 Non-pharmacological treatment of hypertension 
 
Changes in lifestyle are the first steps in the non-pharmacological treatment of hypertension, 
and should be adopted by patients with high normal blood pressure. Excess salt (sodium), 
alcohol, too little physical activity and obesity are risk factors that can be modified. The 
importance of diet as a risk factor for cardiovascular diseases is emphasized already in early 
childhood, when the first indications of endothelial dysfunction and cardio-metabolic 
disturbances in adulthood are evident  (Laitinen et al. 2017).  
 
Nutrition has an essential role in the prevention and treatment of hypertension and other 
cardiovascular diseases. An excessive intake of dietary salt (NaCl) is one of the most 
important blood pressure elevators (Landowne et al. 1949; He et al. 2013). Although sodium 
(Na) is essential for human health in maintaining normal physiological conditions, excess salt 
intake is a risk factor for cardiovascular diseases  (Cook et al. 2016). For instance, increased 
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mortality and the risk of coronary artery disease were associated with a high-salt diet, 
especially in Finnish overweight men  (Tuomilehto et al. 2001). Blood pressure increases only 
slightly during aging, if the individual does not adopt a modern lifestyle and his/her salt 
intake in the diet is minimal. According to the statement of the European Salt Action Network  
(Cappuccio et al. 2018) and Finnish National Guidelines (National Nutrition Council), 
consumption of dietary sodium should be less than 5 g/day. According to the FINDIET2017 
study  (Valsta et al. 2018), 90 % of adults in Finland consume an excess amount of salt in their 
diet. Salt affects blood pressure and health through different mechanisms. For instance, 
excess sodium decreases NO synthesis and increases the production of asymmetric 
dimethylarginine (ADMA), which inhibits the production of NO  (Houston and Harper 2008). 
 
Other electrolytes, potassium (K), calcium (Ca) and magnesium (Mg) lower blood pressure. 
The intake of these electrolytes is an important part of a healthy diet. In a meta-analysis of 
18 randomized controlled trials (RCT), potassium supplementation (≥4 weeks) decreased SBP 
(4.5 mmHg) and DBP (3 mmHg)  (Filippini et al. 2017). The effect was seen especially in those 
subjects with high-sodium consumption, elevated blood pressure with no medication or 
those with a low intake of potassium from their diet.  
 
The effects of dietary calcium are varied. In the recent meta-analysis conducted by Jayedi et 
al.  (2018), the dietary calcium intake was evaluated of participants in eight prospective 
cohort studies (almost 250 000 individuals). The authors indicated that the risk of the 
development of hypertension decreased by 11 % in the highest category of calcium intake 
when compared to the lowest category and 7 % for each 500 mg/d addition to the calcium 
intake. However, it has been suggested that there could be calcification of the coronary 
artery due to calcium supplementation and thus the intake of calcium supplements might 
decrease cardiovascular health  (Tankeu et al. 2017). The author of the review nevertheless 
concluded that dietary calcium intake directly from foodstuffs was not a concern.  In 
experimental studies, calcium has decreased blood pressure with the effect possibly being 
related to smooth muscle function in arteries  (Pörsti et al. 1992; Mäkynen et al. 1994). 
Magnesium supplementation decreased SBP by 3-4 mmHg and DBP 2-3 mmHg based on the 
meta-analysis conducted by Kass et al.  (2012). An interesting review by Borghi and Cicero    
(2017) searched for evidence-based and clinically relevant blood pressure lowering effects 
of different nutrients. They observed that there were some nutrients with promising 
evidence of blood pressure lowering effects e.g. potassium, magnesium, L-arginine, vitamin 
C, cocoa flavonoids, beetroot juice, coenzyme Q10, controlled-release melatonin and aged 
garlic extract. A dose-dependence in the anti-hypertensive effect was evident in these 
studies. Bioactive tripeptides derived from milk have modest blood pressure lowering effects 
as shown by some meta-analyses with relatively small populations  (Xu et al. 2008; Cicero et 
al. 2011; Turpeinen et al. 2013).  
  
A dietary approach to stop hypertension (DASH) -diet has been developed for the prevention 
and treatment of hypertension. Appel et al.  (1997) used the diet for the first time: subjects 
received the DASH diet rich in fruits and vegetables together with low-fat dairy products with 
reduced saturated fat or a diet rich in fruits and vegetables with these being compared 
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against a typical Western diet as the control. Both diets rich in fruits and vegetables 
decreased blood pressure, but the DASH diet was more effective in reducing SBP by 5.5 
mmHg and DBP by 3.0 mmHg. The combination of a low-sodium and DASH diet seems to be 
effective in the treatment of hypertension  (Juraschek et al. 2017). The DASH diet is widely 
used for the treatment of mild hypertension. Basically, diets rich in vegetables, fruits and 
berries together with good lipid profile, such as the Mediterranean diet and the Nordic diet 
have beneficial effects on blood pressure and cardiovascular health  (Ramezani-Jolfaie et al. 
2018).  
 
 
 
To summarize, hypertension is major risk for cardiovascular diseases, organ damage 
and arterial stiffness. Even a slight decrease in blood pressure reduces the risk for 
stroke and other cardiovascular outcomes. Impaired NO bioavailability, vascular 
inflammation and increased reactive oxygen species lead to endothelial dysfunction 
and arterial stiffness, triggering compensatory mechanisms to maintain the vascular 
function. ACE1 inhibitors, AT1 receptor antagonists, thiazide diuretics, calcium-
antagonists and beta-blockers are used for the treatment of hypertension. Together 
with pharmacological treatment, lifestyle habits and diet have a major role in the 
treatment of hypertension and the restoration of endothelial function. Sodium 
increases blood pressure and therefore sodium intake (NaCl) should be minimized in 
order to decrease blood pressure. Other electrolytes, magnesium, calcium and 
potassium have been shown to possess blood pressure lowering effects. 
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2.5 Berries in the prevention of hypertension and vascular 
diseases 
 
Epidemiological and clinical studies have shown that a polyphenol-rich diet is positively 
associated with cardiovascular health  (Mitjavila et al. 2013; Tresserra-Rimbau et al. 2014; 
Rienks et al. 2017). Polyphenol-rich cocoa has been studied widely and claimed to exert 
beneficial cardiovascular effects. The European Food Safety Authority (EFSA) has approved 
a health claim for cocoa flavanols: “Cocoa flavanols help maintain endothelium-dependent 
vasodilatation, which contributes to normal blood flow”  (EFSA Panel on Dietetic Products, 
Nutrition, and Allergies 2012). Flavonoid rich foods have promising effects on endothelial 
function, blood pressure, peripheral and cerebral blood flow.  (Rees et al. 2018) A higher 
intake of flavonoids from fruits has been associated with a lower risk of myocardial infarction 
and ischemic stroke in men (Cassidy et al. 2016). A diet rich in anthocyanins has been 
associated also with lowered blood pressure and mean arterial pressure  (Jennings et al. 
2012). In the SUN cohort study with 17000 participants, those subjects with the highest 
flavonoid-intake had a 47 % lower incidence of cardiovascular events during a ten-year 
follow-up when compared to those in the lowest intake quartile  (Mendonca et al. 2019). 
 
The Nordic diet, which is rich in berries, whole grain, rapeseed oil, fish, fruits, vegetables, 
nuts and low-fat milk-products, has been claimed to be beneficial e.g. lowering mean arterial 
pressure  (Brader et al. 2014). Berries have not been studied widely and randomized 
controlled clinical studies are relatively rare. In this literature review, the focus will be on 
polyphenol-rich berries and their effects on cardiovascular diseases. 
 
2.5.1 Epidemiological studies on berry consumption and health  
 
Epidemiological studies have shown that berry intake exerts positive effects on health.  
Mursu et al.  (2014) found that the consumption of berries was associated with a decreased 
risk of type 2 diabetes in Finnish men. A reduced risk of mortality was associated with a 
higher intake of berries, vegetables and fruits in Finnish middle-aged men  (Rissanen et al. 
2003). A delayed risk of all-cause mortality was observed to be associated with higher 
consumption (over 27 times per month) of vegetables, fruits and berries in a Norwegian 
study, where 10000 men were followed for 40 years and also the mortality due to cancer 
and stroke was lower in those men with a higher consumption of vegetables, fruits and 
berries  (Hjartåker et al. 2015), although no association with berries on their own was seen. 
Larsson et al.  (2013) found that berry consumption was inversely associated with the risk of 
total stroke and cerebral infarction in a ten-year follow-up of 75,000 men and women in 
Sweden. 
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2.5.2 Clinical studies 
 
Berry intake has been shown to have positive effects on cardiovascular diseases  (Heneghan 
et al. 2018). A Finnish research group found that a 150 g berry mix divided into two portions 
per day for eight weeks, lowered blood pressure and positively affected the blood lipid 
profile in middle-aged study subjects  (Erlund et al. 2008). The berry mixture consisted of 
bilberry, lingonberry, strawberry, chokeberry and raspberry. A daily polyphenol dose of 795 
mg in berry juice (150 g bilberries, 50 g blackcurrants, elderberries 50 g, lingonberries 50, 
strawberries 100 g and 100 g tomatoes) for five weeks decreased total cholesterol and LDL-
cholesterol levels in 50-70 year-old study subjects  (Nilsson et al. 2017). The authors also 
found that berry juice enhanced the performance in a memory test when compared to 
control group.  
 
Tjelle and co-workers  (2015) performed a twelve-week randomised double-blinded placebo-
controlled study with polyphenol-rich juices in 134 study subjects, aged between 50-70 
years. The subjects had either high range but normal blood pressure values or stage 1-2 
hypertension. They were treated with 500 ml of 1) commercially available berry juice mixed 
from red grapes, cherries, chokeberries and bilberries; 2) juice similar to (1) but enriched 
with polyphenol-rich extracts from blackcurrant press-residue or 3) a placebo juice 
(polyphenol contents 246, 305 and 76 mg/100 g, respectively). As compared to the placebo 
group, the SBP was significantly lowered after 6 weeks when groups 1 and 2 were combined 
(6.9 and 3.4 mmHg, p<0.01). In hypertensive subjects, the reductions were greater (7.3 and 
6.8 mmHg, p<0.04). A small meta-analysis published by Zhu et al. (2017) investigated the 
blood pressure lowering effects of blueberries in clinical trials conducted before 06/2015; 
overall six randomized controlled trials were included with 204 participants but no significant 
differences were seen in blood pressures.   
 
Blueberry enhanced endothelial function in subjects with metabolic syndrome in a six-week 
study but did not affect the 24 h ambulatory measurement of blood pressure  (Stull et al. 
2015). Johnson et al. (2015) conducted a study in post-menopausal women with 
hypertension or pre-hypertension. The subjects consumed blueberry (Vaccinium virgatum 
and V. corymbosum) powder for eight weeks. Systolic blood pressure was significantly 
lowered in the blueberry group at the end of the study (131 ± 17 mmHg) when compared to 
basal-stage (138 ± 14 mmHg). No significant difference in blood pressure levels occurred in 
the control group between the beginning and the end of the study. However, pulse wave 
velocity in the brachial-ankle was lower in the berry group than in the control group, 
evidence of better elasticity of the arteries. In addition, the level of NO (nitrate/nitrite in 
plasma) was higher in the blueberry group at the end of the study (15.35±11.16 μmol/L) 
when compared to the basal level (9.11±7.95 μmol/L). No differences were evident in the 
control group. 
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Levels of systolic (-9%) and diastolic (-6 %) blood pressure of overweight subjects were lower 
(percentages shown in parenthesis) after the eight week consumption of a blueberry drink 
(corresponding to 350 g of fresh blueberries) than in the control group (-1.5 and -1.2 %, 
respectively). The blueberry drink also decreased the amount of oxidized LDL and the serum 
malonaldehyde concentration  (Basu et al. 2010). A bilberry portion once a day for eight 
weeks (400 g/d) had a positive effect on several inflammatory factors, i.e. CRP, IL-6, IL-12 
and LPS  (Kolehmainen et al. 2012). Systolic blood pressure or oxidative stress markers of 
former smokers were not affected by the consumption of chokeberry extract in the study of 
Xie et al.  (2017), but the total cholesterol and low-density lipoprotein (LDL) cholesterol levels 
were lowered (8 % and 11 %, respectively), diastolic blood pressure slightly increased in the 
chokeberry group when compared to the control group.  Earlier, Kardum et al. (2015) 
showed that chokeberry juice lowered blood pressure (24 h ambulatory) in the 
sympathetically active group (140.8 ± 9.3 mmHg vs. 132.3 ± 15.4 mmHg) and lowered the 
concentration of triglycerides in the blood of sympathetically and parasympathetically active 
groups after four weeks’ consumption, although it is evident that this study was conducted 
without proper controls. Loo et al.  (2016) found that consumption of 330 g chokeberry each 
day lowered daytime diastolic blood pressure slightly (1.7 mmHg) and affected positively on 
IL-10 and TNF-α, when compared to the placebo group. Recently, the intake of a freeze-dried 
bilberry supplement (40 g/d) taken with standard medical therapy for eight weeks enhanced 
the distance that the patients could walk in 6 minutes after an acute myocardial infarction 
when compared to the patients receiving only medical therapy  (Arevström et al. 2019). In 
addition, ex vivo oxidized low-density lipoprotein was lowered in the bilberry group when 
compared to the control group.  
 
RCT trials, investigating blood pressure, vascular function or inflammation with cranberry, 
blueberry, bilberry, blackcurrant and strawberry are listed in Table 2. No RCTs related to CVD 
with lingonberry only were found. Sea buckthorn is not listed, since only a few clinical studies 
examining cardiovascular outcomes have been published in English. However, sea buckthorn 
has been claimed to have the potential to augment cardiovascular health, as it has been 
shown to lower blood lipids and platelet aggregation  (Yang et al. 1999; Johansson et al. 
2000; Guo et al. 2017). Thirty days’ intake of sea buckthorn seed oil decreased systolic blood 
pressure, and also the blood lipid profile was improved  (Vashishtha et al. 2017). 
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Table 2. Randomized controlled trials conducted with cranberry, blueberry, bilberry, blackcurrant 
and aronia. 
 
Reference n Duration Amount  
per day 
Effects on blood pressure, vascular 
function or inflammation 
 
Cr
an
be
rr
y 
 (Ruel et al. 2009) 30 12 wk 
 
125-500 
ml 
BP ↔, Plasma MMP9 ↓ 
 (Dohadwala et al. 
2011) 
44 4 wk 450ml BP ↔, PWV  ↓, FMD ↔ 
 
 (Ruel et al. 2013) 35 4 wk 
 
500 ml Alx ↔ 
 (Novotny et al. 
2015) 
56 8 wk (2x) 240ml DBP ↓, CRP ↓, TAG ↓ 
Bi
lb
er
ry
   
   
   
   
   
   
   
   
Bl
ue
be
rr
y 
 (McAnulty et al. 
2014) 
25 6 wk 
 
250 g * DBP #↓, ASP ↓, Alx ↑, NK cells ↑ 
 (Johnson et al. 
2015) 
48 8 wk 22 g SBP ↓, DBP ↓, PWV ↓, NO ↑ 
 (Stull et al. 2015) 44 6 wk (2x) 45 g BB ↔, RHI ↑ 
 (Curtis, P. J. et al. 
2019) 
115 6 m 150g       FMD ↑, Alx ↑,cGMP↓,  PWV↔, 
BB ↔, NO ↔ 
 (Karlsen et al. 
2010) 
31 4 wk  hsCRP ↓, IL-6↓, IL-15 ↓, 
INF-δ ↓ TNFα ↑ 
 (Kolehmainen et 
al. 2012) 
27 8 wk 
 
400 g Inflammation score ↓ 
(Habanova et al. 
2016) 
36 6 wk (3x) 150 g BP ↔, (Lipid profile 
enhancements) 
Bl
ac
kc
ur
r  (Khan et al. 2014) 66 6 wk 250 ml BP ↔, FMD ↑,F2 isoprostane ↓ 
 (Dalgård et al. 
2009) 
48 28 d 
 
500 ml CRP ↓, IL-6 ↔ 
St
ra
w
be
rr
y 
 (Basu et al. 2010)  27 8 wk 
 
500 g* BP ↔, tCHOL ↓, LDL ↓, VCAM ↓ 
 (Basu et al. 2014) 
 
60 12 wk 250 g* 
500 g* 
BP ↔, LDL ↓, MLD ↓ 
 (Amani et al. 
2014)  
36 6 wk  DBP ↓ 
 (Feresin et al. 
2017) 
20 8 wk 
 
25 g# 
50 g# 
BP ↔, PWV ↔ 
Ch
ok
e.
  (Loo et al. 2016) 37 8 wk 
 
300 ml DBP ↓ 
MMP9=matrix metalloproteinase, PWV=pulse wave velocity, FMD=flow-mediated dilatation, Aix=augmentation 
index, TAG=triacylglycerol, ASP=aortic systolic pressure, RHI=reactive hyperemia index, IL=interleukin, 
INF=interferon, TNFα=tumor necrosis factor α. *powder, corresponding amount of berries, #amount of powder. 
2x/3x = daily portion. ↓/↑ =p<0.05, ↔ = p=ns. 
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2.5.3 Effects of lingonberry on cardiovascular health 
 
There are rather few clinical studies conducted with lingonberries and none of them have 
focused on vascular diseases. Instead, lingonberries have been evaluated in association with 
blood glucose and glycemia. A strong hyperglycemic profile in response to sucrose was 
significantly improved at two hours after ingestion of lingonberry puree (150 g) with 35 g 
added sugar when compared to sucrose diluted in 300 ml of water in healthy women in a 
randomized controlled meal study conducted by Törrönen et al. (2012). The effect of 
lingonberry nectar (300 ml, 50 % of berry) was slightly milder. Similar effects were seen in 
another study, where glucose and fructose were used instead of sucrose, to mimic the 
conversion of sucrose into glucose and fructose in solutions with acidic pH values  (Törrönen 
et al. 2017). In both studies, lingonberry affected the insulin response, but it was not able to 
clearly lower the glucose level in blood. Furthermore, when lingonberry (150 g) was served 
with wheat bread (50 g of starch), the insulin response was lowered when compared to 
control meal (the same bread and 50 g cucumber with water)  (Törrönen et al. 2013). The 
sugars present in the lingonberry itself did not seem to increase blood glucose, probably due 
to compensatory effects of polyphenols and/or fibre  (Linderborg et al. 2012). 
 
Most studies on health effects of lingonberries have been conducted in animals. In mice, 
lingonberry prevented weight gain and the development of fatty liver due to feeding a high-
fat diet  (Heyman et al. 2014). Matziouridou et al. (2016) found that the vascular plaque size 
in APO E-/--mice was reduced and the amount of triglycerides in blood was decreased, when 
food was fortified with 44 % (weight) lingonberry for eight weeks. In the same study, 
lingonberry also altered the composition of the gut microbiota. Fatty liver formation and 
diabetes were studied in C57BL/6-mice, which were fed a high-fat diet and dried lingonberry, 
bilberry, blackcurrant or acai berries for 13 weeks  (Heyman-Linden et al. 2016).  Lingonberry, 
bilberry and blackcurrant diminished the effects of the high-fat diet, such as fatty liver 
formation and disturbances in fat metabolism by reducing low-grade inflammation and acute 
phase reactions. Interestingly, acai-berries increased the formation of fatty-liver. Beneficial 
effects on lipids were seen also with lingonberry anthocyanin extract, when mice with 
induced hypercholesterolemia were given the extract for 10 weeks  (Zhang et al. 2019). The 
lingonberry anthocyanin extract reduced the visceral adipose content, total cholesterol and 
LDL-cholesterol levels. Body mass and daily food intake were also lower and HDL-cholesterol 
level higher when compared to the control group. In streptozotocin-induced diabetic mice, 
lingonberry extract was able to restore the density of purinergic receptors and decrease the 
oxidative stress related to diabetes  (Reichert et al. 2018).  The extent of a renal injury was 
diminished in ischemia-perfused Sprague-Dawley rats after three weeks’ treatment with 
lingonberry juice and also the level of injury-induced inflammation was decreased (Isaak et 
al. 2017). Interestingly, when lingonberries from two different origins were tested in mice 
consuming a high-fat diet, only lingonberries from one location were able to improve 
glycemia in the mice, but berries from both sites were able to improve liver function and 
inflammation when compared to the control group  (Al Hamimi et al. 2017). The anti-
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oxidative actions of lingonberry have been investigated mostly in in vitro studies. 
Lingonberry polyphenols are able to donate electrons and thus exert antioxidant activities 
by chelating and quenching free radicals  (Zheng and Wang 2003; Määttä-Riihinen et al. 
2005; Drozdz et al. 2017). 
 
 
 
To summarize, berries and other polyphenol-rich diets can enhance cardiovascular 
health. Berry intake has been associated with lowered blood pressure, improved 
vascular function and has exerted a beneficial effect on the blood lipid profile. Bilberry, 
blueberry and strawberry have been the most extensively studied berries in this respect 
and their positive effects on blood pressure, low-grade inflammation and vascular 
function have been reported in randomized controlled clinical trials.  However, more 
evidence should be gained with controlled amounts of polyphenols. Only a few clinical 
studies have been conducted with lingonberries. In those studies, lingonberry improved 
the glycemic profile after consumption of sugars or starch. In preclinical studies 
conducted in experimental animals, lingonberry treatment has been associated with 
positive effects on the blood lipid profile, fat metabolism, inflammation and oxidative 
stress.  
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2.6 Polyphenols in berries 
 
Polyphenols are aromatic chemicals and secondary metabolites synthetized by plants to 
combat different threats, like UV-radiation and pathogens. Flavonoids and different phenolic 
acids are some of the most common groups of polyphenols. About 8000 polyphenols have 
been identified and 4000 of them are classified as flavonoids. In plants, polyphenols are 
usually present as glycosides or acylated in sugars. The classification of polyphenols can be 
made by their chemical- or bioactive structures or origin. See (Tsao 2010). Polyphenols can 
be roughly divided into flavonoids, and non-flavonoids. Examples of flavonoid classes and 
subclass are listed in Table 3 and non-flavonoid polyphenols in Table 4  (Manach et al. 2004; 
Tsao 2010; Goszcz et al. 2017). There are some seasonal and growth place variability in the 
polyphenolic contents of berries, for example, the anthocyanin amount seems to be 
dependent on growth conditions, with the amount being highest at low temperatures 
(Hykkerud 2018). 
 
 
2.6.1 Flavonoids 
The basic structure of all flavonoids is a three-phenol ring C6-C3-C6, diphenylpropane. 
Flavonoids are classified in subgroups according to their heterocyclic C-ring. Usually, 
flavonoids are present in plants as glycosides. Bioactivity is affected by the structure and 
glycosylation state. The most common flavonoids (Table 3) are flavones, flavonols, 
flavanones and flavanoles (3-hydroxy derivate of flavanones), which are found in most of the 
plants. The largest subgroup of polyphenols consists of flavones and their 3-hydroxy derivate 
flavonols. For instance, two flavonols, quercetin and kaempferol, have about 300 different 
glycoside structures. Flavanols (flavan-3-ols), so-called catechins have two chiral centers and 
thus four different stereoisomers i.e. epicatechin is a cis- and catechin is a trans- isomer. 
Both forms have also stereoisomers, (+)-epicatechin, (-)-epicatechin, (+)-catechin ja (-)-
catechin. Polymers consisting of epicatechins and catechins are called proanthocyanidins. 
Further anthocyanins are formed when proanthocyanidins are cleaved under acidic 
conditions. Proanthocyanidins, so-called condensed tannins, are oligomers consisting of 2-
11 flavanols. A- and B-type proanthocyanidins differ by the bonds linking the flavanol units. 
Flavanols and proanthocyanidins are able to act as strong antioxidants and the ability seems 
to correlate with the polymerization rate. Anthocyanidins occur most often as glycosides, i.e. 
anthocyanins. The red, blue and purple colours in plants are based on anthocyanins, with 
most common being cyanidin, delphinidin and pelargonidin. In acidic conditions, 
anthocyanins are bright red in colour, whereas in more neutral conditions they are blue. In 
addition, hydroxylation, aromatic rings and glycosylation affect colour formation.  (Manach 
et al. 2004; Tsao 2010) 
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Table 3. Flavonoid classes and example of compounds and common dietary source. 
Flavonoid 
class 
Subclass Example of these compounds Dietary Source 
Anthocyanins Cyanidin    
(R1=OH, R2=H) 
Delphinidin  
(R1,2=OH) 
Pelargonidin 
(R1,2=H) 
berries, black 
beans, eggplant, 
red wine 
Flavan-3-ols,  
Flavanols 
(+)-Epicatechin 
(R1,2=H) 
Gallocatechin 
(R1=H, R2=OH) 
Procyanidins  
(condensed tannins) 
tea, hazelnuts, 
berries 
Flavanones Naringenin     
(R1=H, R2=OH) 
Hesperidin 
(R1=OH, R2=OCH3) 
 
citrus fruits, 
vegetables 
Flavones Apigenin  
(R=H) 
Luteolin  
(R=OH) 
Baicalein 
 
fruit, vegetables 
Flavonols Quercetin 
(R1=H, R2=OH) 
Kaempferol   
(R1=H, R2=H) 
Myricetin 
(R1,2=OH) 
 
 
onions, berries, 
chili peppers, 
broccoli 
Isoflavonoids Genistein 
(R1=OH, R2,3=H) 
Daidzein  
(R1,2,3=H) 
 
soybeans 
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Table 4. Non-flavonoid polyphenol classes with example compounds and common dietary source. 
Class Subclass Example of compounds Dietary Source 
Phenolic acids Chlorogenic acid 
(R=5-quinoyl) 
Caffeic acid  
(R=H)  
Hydrolysable tannins 
Berries, grape, 
coffee, tea, 
eggplant 
Stilbenes Resveratrol 
 
Red wine, 
berries, 
grapes, cacao, 
peanuts  
Lignans Secolariciresinol Flax, sesame, 
grains, berries 
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2.6.2 Lingonberry and its polyphenols 
 
Lingonberry, Vaccinium vitis-idaea, is the most high-yielding forest berry in Finland. 
According to the National Institute of Health and Welfare database, lingonberry contains 
energy amounting to approximately 56 kcal/100 g. It is rich in vitamin E (α-tocopherol) and 
there are also A-, B- and K-group vitamins  (National Institute for Health and Welfare, 
Nutrition Unit. Fineli.). Minerals potassium, calcium, magnesium, phosphorus are present 
and also iron and zinc can be detected in trace amounts. Linoleic, α-linolenic fatty acids and 
sterols are also present in lingonberries. The total fibre content is 2.6 g/100 g and the sugar 
content is 8.2 g/100 g, most of which are fructose and glucose. Based on food components 
and conditions assessed by Regulation (EC) No 1924/2006 of the European Parliament and 
of the Council on Nutrition and Health about claims made on foods, the following nutrition 
claims can be made about lingonberry: high fibre, low fat, saturated fat free, low sodium and 
natural source of vitamin E. 
 
Lingonberries contain several complex phenolic compounds. Catechins, epicatechins and 
their polymers, A- and B-type proanthocyanidins have been identified  (Ek et al. 2006, 
Hellström et al. 2009). A-type proanthocyanidins are more abundant in Finnish lingonberries; 
their amounts (298-548 mg/100 g) seem to be highly dependent on growing conditions, 
seasonal differences, state of maturity and harvesting conditions (Hellström et al.  2009). 
The anthocyanins found in lingonberries were cyanidins, 77  and peonidins 0.6 mg/100g of 
fresh weight (Koponen et al. 2007). Häkkinen et al. (1999) found only quercetin, 74 and 146 
mg/kg, whereas quercetin, kaempferol and myricetin were detected in Finnish lingonberries 
grown in different places. 
 
In lingonberries from western Finland, 1-O-benzoyl-b-glucose was the most common 
phenolic (41 %) analysed (Tian et al. 2017). One quarter of the phenolics consisted of flavan-
3-ols including (+)-catechin (22%) and (-)-epicatechin (3%). Cyanidin-glycosides were the 
most common anthocyanins (11 %) but also A-type procyanidin trimers and B-type dimers 
were found (9 %). In addition, some flavonol glycosides and derivatives from 
hydroxycinnamic acid were detected.   
 
In another rather recent study with Romanian lingonberries, anthocyanin compounds 
bonded with an ethyl-bridge were found; cyanidin-pentoside and cyanidin-acetylhexose  
(Bujor et al. 2018). A total of 120 different phenolic compounds was identified in 
lingonberries.  
 
Stem and leaves were richer in phenolics than the berries (Bujor et al. 2018). Most of the 
phenolic compounds in stems and leaves were flavanols (72-71 % and 27-42 %, respectively) 
whereas in the berries, the amount of flavanols was about 30-36 %. Some oligomeric 
flavanols were found e.g. eight B-type dimers, nine B-type trimers, five A-type dimers and 
four A-type trimers. Monomeric flavanols (+)-catechin and (-)-epicatechin were found in all 
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parts of the plants. Gallocatechin and -(-)-epigallocatechin were found from all parts of 
lingonberry. In addition, four different cinchonines were found. In berries, flavanol 
glycosides accounted for 7-9 % of total weight, e.g. 18 different quercetin-glycosides were 
found, as well several kaempferol glycosides. Acids, like hydroxycinnamic acid, caffeolytic 
acid and p-coumarinic acid represented 2-3 % of the lingonberry polyphenols.  
 
In addition to flavonoids and phenolic acids, lingonberries contain also lignans and stilbenes. 
The lignans that have been detected in Finnish lingonberries include lariciresinol, pinoresinol 
(586 μg/100g) and secoisolariciresinol (19 μg, 586 μg and 140 μg/100g of fresh weight, 
respectively) (Nurmi et al. 2010). Resveratrol was the only stilbene found in lingonberries, 
when resveratrol, pterostilbene and piceatannol were found in Vaccinium-berries (Rimando 
et al. 2004). The resveratrol concentration was highest in lingonberries (588 μg/100g), when 
compared to the corresponding concentrations in other berries.  
 
 
 
To summarize, dietary polyphenols are phenolic compounds categorized roughly into 
flavonoids and non-flavonoids. Flavonoids, about 4000 different compounds are 
further subdivided to anthocyanins, flavanols, flavanones, flavones, flavonols and 
isoflavonoids. Non-flavonoid compounds are phenolic acids, stilbenes and lignans. 
Lingonberry grows widely in Nordic forests, it is rich in polyphenols and it contains also 
vitamins, minerals and other nutrients and fibre. Lingonberry contains complex 
polyphenols e.g., anthocyanins, catechins, epicatechins, procyanidins and flavonols. In 
addition, lignans and stilbenes are found. The polyphenol content differs depending on 
growth conditions, with some types of polyphenols being more sensitive to changes.  
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2.7 Bioavailability and safety aspects of polyphenols  
 
The bioavailability of polyphenols is the key question when the health effects of polyphenols 
and flavonoids are examined. The metabolism of these bioactive compounds are not yet fully 
understood. The most abundant polyphenols in food might not be the one that are dominant 
in tissues and circulation. Usually, the bioavailability of polyphenols is rather low and their 
metabolism is extensive. The active compound behind the actions of the flavonoids is usually 
the conjugated metabolite digested from intestine or some other chemical form produced 
by the gut microbiota (Williamson et al. 2018). 
 
2.7.1 Bioavailability and food matrix interactions  
The first steps of the absorption of polyphenols are the cleavage of the sugar molecule and 
the diffusion of the phenolic aglycone to intestinal absorptive cells, enterocytes in the 
duodenum and the proximal half of jejunum. Glucuronidation, methylation or sulfonation of 
the aglycons occurs in phase II metabolism before the compounds gain access to the 
circulation as sulphate, glucuronide and/or methylated metabolites. From the circulation, 
these metabolites can return to small intestine lumen or be distributed to liver for further 
metabolism. The return to small intestine is possible because of enterohepatic transport into 
the bile (enterohepatic circulation similarly as occurs for some drugs). The microbiota in the 
large intestine and colon can cleave polyphenols and metabolites not absorbed in small 
intestine to produce phenolic acids and hydroxycinnamates for further degradation.  (Del Rio 
et al. 2010). Different colonic microbiota species, such as Lactobacillus, Eubacterium, 
Bifidobacterium and Clostridium are now appreciated as having an impact on polyphenol 
metabolism. For instance, kaempferol is transformed to 2-(4-hydroxyphenyl)propionic acid 
by Clostridium orbiscidens and catechin to 3-(3-hydroxyphenyl)propionic acid or 5-(3’,4’-
dihydroxyphenyl)-?-valerolactone by Clostridium coccoides or Bifidobacterium spp. (Marin 
et al. 2015) Correspondingly, the presence of polyphenols can alter the gut microbiota. For 
instance, bifidobacteria and lactobacilli become enriched in the gut after polyphenol 
consumption  (Sheflin et al. 2017). There seems to be heterogeneity in the urinary excretion 
of polyphenol metabolites, e.g. the excretion of γ-valerolactones was higher in young (26 ± 
6 years) than in older people (70 ± 4 years) when differences in ADME of cocoa flavanols 
were studied  (Rodriguez-Mateos et al. 2015). In the same study, slight differences were seen 
in plasma levels of epicatechin metabolites, and the authors suggested that the normal age-
related decline in renal function might affect plasma levels of glucuronidated and sulfated 
metabolites.  
 
Manach et al. (2005) reviewed the bioavailability 19 major polyphenols from 97 different 
studies. They noted that gallic acid and isoflavones were the best absorbed polyphenols, 
followed by catechins, flavanones and quercetin glucosides. Proanthocyanidins, galloylated 
 48 
 
tea catechins and anthocyanins were more poorly absorbed. There were also major 
differences in the kinetics of the different polyphenol classes. Anthocyanins might have 
better bioavailability than thought previously. A new technique with isotopic labeling has 
detected more metabolites of cyanidin-3-glucoside than when the blood was assayed with 
older techniques (Czank et al. 2013). Cyanidin-3-glucoside (C3G) pharmacokinetics was 
studied (in 8 healthy males) by Ferrars et al. (2014). C3G and its degradation products, 
phloroglucinaldehyde (PGA) and protocatechuic acid (PCA), were found in the serum 
together with 13 different metabolites of PCA and one PGA metabolite, with hippuric acid 
and ferulic acid being the major metabolites. Maximal concentrations were attained 
between 2 to 30 h after consumption, and elimination half-lives ranged between 0.5-96 h. 
Lehtonen et al. (2009) investigated cyanidin 3-O-galactoside anthocyanin and its metabolites 
obtained from lingonberries. Healthy subjects received 300 g of lingonberries as a part of 
their breakfast, with the metabolites being detected from urine samples by uHPLC-MS/MS. 
Maximal excretion occurred at 4 to 8 h after meal. Methylated (peonidin galactoside) and 
glucuronidated (cyanidin glucuronide) metabolites as well intact cyanidin 3-O-galactoside 
were found.  
 
The food matrix affects the bioavailability of the berry polyphenols. Proteins, lipids and 
carbohydrates and polyphenols have different interactions either enhancing or decreasing 
each other’s bioavailability. Interactions between proteins and polyphenols are often 
reversible, noncovalent and hydrophobic. Proteins might prolong the polyphenol stability 
whereas the dietary fibre and carbohydrate digestion can be slowed down.  (Kardum and 
Glibetic 2018).   
 
 
2.7.2 Safety issues  
 
Safety issues surrounding berries have been discussed based on safety data related to certain 
polyphenols, like anthocyanins. The safety of lingonberry alone has not been evaluated in 
the literature. In 2013, the European Food Safety Authority (EFSA) has made a safety re-
evaluation of anthocyanins used as a food additive  (EFSA Panel on Food Additives and 
Nutrient Sources added to Food (ANS) 2013). EFSA stated that there was not enough 
available toxicological data for setting a numerical acceptable daily intake (ADI) for 
anthocyanins. According to toxicological studies conducted on animals administered 
anthocyanins from currants, blueberries or elderberries, no acute toxic effects occurred 
when the intake was 20 mg/kg/d in rats and 25 mg/kg/d in mice  (Wallace and Giusti 2015). 
After exposure for either 15 or 90 days, there were no toxic effects with doses >3 g/kg/d in 
guinea pigs and rats and in generation studies, 9 g/kg/d in rats, mice and rabbits did not 
evoke any toxic effects over 3 generations. In mice, rats and rabbits, acute oral toxicity has 
been assessed by EFSA. An extract from currants, blueberries and elderberries which is rich 
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in cyanidin, petunidin and delphinidin was studied. The values of the LD50 (lethal dose 50 %) 
for mice and rats were assessed as 25 000 and 20 000 mg/kg of body weight. Anthocyanins 
are used as a food additive (food colour) with an e-code E 163. Maximum permitted levels 
(MLPs) according to the Commission Regulation (EU) No 1129/2011 are listed in EFSAs 
Scientific Opinion. In most foods, anthocyanins can be added as a quantum satis principle 
(the amount enough), with few restriction/exceptions. 
Several manufacturers want to produce synthetic polyphenols and commercialize those as 
food supplements. The EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) has 
made an evaluation of synthetic trans-resveratrol as a novel food. The conclusion of the 
panel was that a daily dose up to 150 mg/day as a supplement for adults would be safe under 
the few conditions assessed. Diarrhea and other gastrointestinal symptoms might occur 
when the daily dose of resveratrol exceeded 1000 mg. The panel noted that the sulphated 
metabolite of trans-resveratrol might inhibit cytochrome P450 enzymes (CYP) in humans and 
thus medicines metabolized through CYP2C9 could undergo interactions with trans-
resveratrol. It is becoming more evident, that P450 enzymes (the family including CYP2C9) 
interact with polyphenols. Interactions between polyphenols and CYP3A4, an enzyme 
regulating gut and liver metabolism of xenobiotics and drugs, have been investigated 
recently. According to the review conducted by Basheer and Kerem (2015), flavonols such as 
kaempferol and quercetin as well as many other flavonoids and the non-flavonoid 
resveratrol can inhibit CYP3A4. In contrast, tangeretin (a citrus flavone) was found to activate 
the enzyme. Inhibition of CYP enzymes may elevate the plasma concentration of drugs 
metabolized by those CYPs and thus accentuate the effects of the drug and increase the 
possibility of adverse effects (Pelkonen et al. 1998). For example, resveratrol has been shown 
to alter the pharmacokinetic properties of diclofenac (an NSAID) by elevating its maximum 
plasma concentration, possibly due to CYP-inhibition (Bedada et al. 2015). 
 
 
 
To summarize, polyphenols are commonly metabolized by glucuronidation, 
sulphonation or methylation. The colonic microbiota has a major effect on bioavailability 
of the polyphenols and conversely, polyphenols can alter the gut microbiome. This can 
lead to differences in the bioavailability of the polyphenol between individuals. It can be 
concluded that the health-promoting effects of polyphenol-rich foods are the sum of 
different types of polyphenols and their interactions with gut microbiota and individual 
characteristics. Polyphenols are metabolized rather rapidly, within a few hours, but also 
after 36 h of digestion, some metabolites have been detected in plasma and urine. The 
consumption of polyphenol-rich food safety has not been studied. Dietary polyphenols 
might affect drug metabolism through the CYP-family.  
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3 AIMS OF THE STUDY 
Nutrition plays a major role in the prevention of hypertension and endothelial dysfunction 
starting from early childhood and lasting throughout the individual’s lifetime. Berries and 
fruits are rich in polyphenols. Polyphenols are naturally occurring phytochemicals present in 
plants; some of these compounds have been shown to be associated with improved 
cardiovascular health. The molecular structure of aromatic polyphenols enables these 
compounds to act as radical scavengers and enzyme inhibitors, which might be the 
mechanisms behind their cardiovascular effects.  
In this project, the effects of polyphenol-rich berries on vascular function and hypertension 
were explored. The first part of this study was to evaluate the effects of cranberries, 
lingonberries and blackcurrants on endothelial function of mesenteric arteries. The second 
part of this project investigated the effects of lingonberries on blood pressure and on low-
grade inflammation. Finally, the mechanisms behind the vascular effects of lingonberries 
were investigated.  
 
The specific aims were: 
 
1) to study whether cranberry, blackcurrant and lingonberry juices could inhibit the 
development of vascular dysfunction.  
 
2) to investigate if lingonberry juice affects the development of hypertension and 
whether elevated high blood pressure could be lowered by long-term treatment 
with lingonberry juice. 
 
3) to explore the mechanisms contributing to the prevention of vascular dysfunction 
and hypertension by lingonberry juice and how the inflammatory status could be 
affected by berry juice.  
 
4) to determine the effects of lingonberry juice on blood pressure, kidney function and 
inflammation in a salt-loaded rat model.  
 
5) to examine if COX2 is involved in the vascular effects of lingonberry.    
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4 MATERIALS AND METHODS  
 
4.1 Study models and designs 
 
This project comprise of four studies. The studies are briefly presented with the main 
methods in Table 5.   
 
Table 5. Study models and main methods. 
 Study I Study II Study III Study IV 
Experimental 
model  
SHR 
normal diet 
SHR 
normal diet 
SHR, WKY 
normal diet 
WKY, normal 
and high-salt 
(HS) diet 
Age (weeks) 6 6 9 8 
n 6 6 8 8 
Berry juice(s) lingonberry, 
cranberry and 
blackcurrant 
lingonberry, 
cranberry and 
blackcurrant 
lingonberry lingonberry 
Treatment 
period 
8 weeks 8 weeks 8 weeks 
10 weeks (WKY) 
10 weeks 
Diet Normal Normal Normal Normal +          
       8 % NaCl 
Methods  SBP, vascular 
reactivity 
 SBP, DBP, vascular reactivity 
Molecular 
biology 
methods 
 
 
ELISA 
QPCR 
ELISA 
Clinical 
chemistry 
Electrolytes 
ACE-activity  
ELISA 
QPCR 
Clinical 
chemistry 
Electrolytes 
 
 
4.1.1 Animal models (Study I-IV) 
 
Spontaneously hypertensive rats (SHR) were used in studies I-III as a model of hypertension 
and vascular dysfunction. Hypertension in SHR is genetically programmed and starts to 
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develop when the animals are a few weeks old and increases to about 200 mmHg during 
their first two-three months (Pinto et al. 2018).  Wistar Kyoto (WKY) rats were used as 
normotensive controls for SHRs (studies III-IV). Rats were purchased from Charles River 
laboratories (Sulzfeld, Germany) at the age of 5-6 weeks.  
A high-salt diet was provided to the WKY rats in study IV as a model of diet-induced 
hypertension and inflammation. The high-salt diet was a normal rodent diet enriched with 
NaCl (8%).  Control groups received a normal rodent diet (Harlan, Venray, The Netherlands).  
Rats had free access to feed and drink. Rats were housed in a standard animal laboratory 
housed four to six in a cage according to their weight and baseline SBP so that each group 
(cage) had rats of approximately same mean weight and SBP.  
The protocol of the studies was approved by the National Animal Experimentation 
Committee according to EC Directive 86/609/EEC and Finnish Experimental Act 62/2006.  
 
 
4.1.2 Berry juices (Study I-IV) 
 
Frozen berry purees were cold-compressed in the lab and diluted with water (1:3 in Studies 
I and II, 1:5 in Studies III and IV) every 3 days and stored in a fridge before being provided to 
the rats. Sucrose was added to the juice, in studies I-II, 4 % and in a more diluted juice 
(Studies III-IV), 1 %, to make the drinks more palatable. In studies III and IV, also the tap water 
given to the control groups was enriched with 1 % sugar. Drinking fluid and feed consumption 
were recorded by weighing the amounts before and after portioning to rats. The results were 
calculated per cage and divided by the number of rats in the cage. The polyphenolic contents 
of berry juices were measured by UHPLC and are listed in Table 6.  
 
Table 6. Polyphenolic contents of the berry juices in studies I-IV assessed as mg/100g by UHPLC.  
 Lingonberry Blackcurrant Cranberry Lingonberry 
Study I, II I, II I, II III, IV 
Polyphenols total 65.2 55.4 29.4 34.1 
Hydroxybenzoic acid 0.3 0.1 0.1 0.1 
Hydroxycinnamic acid 5.3 4.5 5.2 2.5 
Anthocyanins 14.4 39.9 12.4 5.9 
Flavonols 11.0 6.5 5.7 3.8 
Flavan-3-ols 11.2 nd 0.7 3.0 
Procyanidins 23.0 4.4 5.3 18.7 
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4.2 Methods 
 
4.2.1 Blood pressure measurement (Study I, III, IV) 
 
Blood pressure was measured once a week using the tail-cuff method. In studies I and II, only 
SBP and heart rate were measured (Apollo-2AB Blood Pressure Analyzer, Model 179-2AB, 
IITC Life Science, Woodland Hills, CA, USA). In studies III and IV, DBP was also measured 
(CODA, Kent Scientific Corporation, Torrington, CT, USA).  In each study, the measurements 
were made by the same researcher (Kivimäki) at the same time of day, before noon. Before 
the measurements, rats were warmed in a heated chamber (32 ˚C) for 10-20 min in aeriated 
cylinder tubes in order to make tail artery pulsation more intense and detectable. The 
measurement rooms were different; in studies III and IV, the blood pressure measurement 
was conducted in a more quiet and spacious room. In studies I and II, three correct and 
undisturbed consecutive SBP and HR measurements out of a total of ten were averaged. SBP, 
DBP and HR measurements in studies III and IV were conducted in three sets, each set 
consisting of eight measurements. Measurements accepted by the CODA-program were 
then calculated and averaged. Blood pressure measurement with CODA-instrument was 
more automated than with Apollo-analyzer.  
Mean arterial pressure was calculated with the equation (???+1/3 (???−???) in study III. 
 
 
4.2.2 Vascular reactivity studies (Study I, III, IV) 
 
At the end of the treatments, mesenteric arteries were dissected and cleaned from adherent 
connective tissue in pre-oxygenated Krebs-solution. From the proximal end of the 
mesenteric artery-aorta junction, a 3-4 mm section of a vessel was removed and the 
following 3-4 mm piece were used for reactivity studies. Mesenteric artery rings were 
hooked between stainless steel hooks and incubated in an organ-bath chamber for one hour 
with a resting tension of 1.0 g (Study I) and 1.5 g (Study III,IV) (volume 10 ml). Baseline levels 
of resting tension were taken into account when the force of constriction was calculated. 
Krebs solution in the chamber (pH 7.4–7.6, composition in mmol/l: NaCl, 119.0; NaHCO3, 
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25.0; glucose, 11.1; CaCl2, 1.6; KCl, 4.7; KH2PO4, 1.2; MgSO4, 1.2) was pre-warmed in 37 ˚C 
and oxygenated with O2/CO2 (95%/5%, AGA, Riihimäki, Finland). An isometric force-
displacement transducer (EMKA Technologies, Paris, France) was used for continuous 
measurement of the force of contraction by arterial rings. 
After the incubation, the reactivity of the mesenteric arteries was tested by vasoconstricting 
or vasodilating drugs. Drugs were dosed to organ-bath chamber cumulatively (Ach, SNP) or 
once (PE, diclofenac, L-NAME).  
 
Drugs and their mechanisms were as follows: 
? Testing of contraction and relaxation ability of the arteries: 60 mM potassium 
chloride (KCl), 1 μM acetylcholine (Ach) 
? Pre-contraction before endothelium- and non-endothelium-dependent relaxation: 1 
μM phenylephrine (PE)  
? Cumulative endothelium dependent relaxation: 1 nM - 0.1 μM Ach 
? Inhibition of COX-derived relaxation: + 3 μM diclofenac 
? Inhibition of eNOS-derived relaxation: + 100 μM L-NG-nitroarginine methyl ester (L-
NAME) 
?  The role of EDHF: diclofenac + L-NAME 
? Calcium-activated potassium channels KCa response: 0.1 μM apamin + 1 μM TRAM-
34 
? Cumulative endothelium-independent relaxation: sodium nitroprusside (SNP), 1 
nM–0.1 μM 
 
 
4.2.3 Biochemistry and clinical chemistry (Studies II-IV) 
 
Collection of samples 
Organ and blood samples were collected after the end of the experiment (study II-IV). Urine 
samples were collected during the 24 h metabolite caging (study III, IV) during treatment 
week 7.  
 
Biochemical measurements 
Biochemical measurements are summarized in Table 7. Enzyme-linked immunosorbent 
assays (ELISA) in studies II-IV are listed in Table 7 were conducted according to the 
manufacturer’s instructions from plasma, serum or urine samples. Gene-expression analysis 
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assessed by the real-time quantitative polymerase chain reaction (RT-qPCR) (Study II, IV) 
were made from aortic samples. Prior to qPCR mRNA was isolated by Trizol Reagent 
(Invitrogen, Paisley, Scotland, UK) according to the manufacturer´s instructions. cDNA 
synthesis was performed from 1 μg of RNA by reverse transcription with SuperScript VILO 
cDNA Synthesis Kit (Life Technologies, Paisley, Scotland) according to the manufacturer’s 
instructions. Primers for qPCR were designed with the National Center for Biotechnology 
Information (NCBI)/Primer-BLAST –tool. The primers were optimized to obtain 90-110 % 
efficacy. SYBR Green –chemistry reagents (Brilliant II SYBR Green master mix, Agilent 
Technologies) were used for relative quantitation. Relative gene-expression results were 
calculated using 2-ΔΔCt-method  (Livak and Schmittgen 2001). ACE1 activity of serum and 
kidney lysate were measured according to Santos et al. (1985) (Study III, IV). 
 
Table 7. Biochemical measurements in Studies II-IV. Plasma (p), serum (s), urine (u), aorta (a) or 
kidney (k) samples. 
Biochemical variable Method Sample Study 
Aldosterone ELISA p III, IV 
Angiotensin II ELISA p II 
ADMA ELISA p II 
hs CRP ELISA p II, III, IV 
ICAM ELISA s III, IV 
IL-6 ELISA p II 
IL-10 ELISA p III, IV 
TNF α ELISA p II 
NOx ELISA p II, III, IV 
8-isoprostane ELISA p II 
6-keto PGF1α ELISA p III, IV 
Albumin ELISA (urine) u III, IV 
cGMP ELISA (urine) u III, IV 
Creatinine ELISA (urine) u III, IV 
ACE1, *activity RT qPCR, *act. assay a, s*, k* II, III, IV 
Adiponectin RT qPCR a II 
COX2 RT qPCR a II, IV 
MCP1 RT qPCR a II 
p-selectin RT qPCR a II 
V-CAM RT qPCR a II 
See list of abbreviations in page 7. 
 
Clinical chemistry  
Clinical chemistry measurements were conducted with automated ADVIA 1650 Chemistry 
System (Siemens Healthcare Diagnostics Inc., Deerfield, IL, USA). Alanine aminotransferase 
(ALAT), alkaline phosphatase (ALP), aspartate transaminase (AST), creatinine (Crea), albumin 
(Alb), urea, creatine kinase (CKNAC), total bilirubin (TBil), inorganic phosphate (Pi), glucose 
(Glu), high-density lipoprotein cholesterol (HDL), low-density lipoprotein cholesterol (LDL), 
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triglycerides (TG), total cholesterol (TC) and electrolytes (K, Na, Cl, Ca) were measured (study 
III, IV). Urine electrolytes and albumin were also measured in study IV. 
4.2.4 Immunohistochemistry (additional data) 
 
COX2 was measured immunohistochemically from kidney samples (Studies III and IV). 
Immunohistochemical analyses were made from paraffin-embedded 5 mm kidney sections. 
Paraffin blocks were sliced and fixed in Menzel-Gläser SuperFrost Ultra Plus -glasses. Paraffin 
was removed with Xylene-EtOH-H2O washing protocol. Unmasking the epitopes was done in 
prior to actual staining with LabVision Autostainer (Thermo Fisher Scientific). The primary 
antibody was COX2 (D5H5) XP® Rabbit mAb (Cell Signaling Tehn.). Polyclonal HRP-Anti-
Mouse IgG (ImmunoLogic, Netherlands) was used as a secondary antibody.  
Images were generated using 3DHISTECH Pannoramic 250 FLASH II digital slide scanner 
at Genome Biology Unit supported by HiLIFE and the Faculty of Medicine, University of 
Helsinki, and Biocenter Finland. Pictures were analyzed with Case Viewer 2.3.  
COX2 expression in the macula densa of kidney cortex: Randomly picked 40 glomeruli were 
calculated and the COX2 positive macula densa area was counted (%).  
 
 
4.2.5 Molecular docking (additional data) 
 
As described in Chapter 2.6.2, lingonberry contains kaempferol glycosides. Different 3D-
structures where kaempferols (Preferred IUPAC name 3,5,7-trihydroxy-2-(4-hydroxyphenyl)-
4H-1-benzopyran-4-one) are attached to proteins were searched from the Protein Data Bank 
(PDB) -database (www.rcsb.org). The orientation of kaempferol ring structures were 
analysed. Four of the 10 different structures in natural were selected and differences in 
rotation were evaluated.  
The structure of a selective COX2 inhibitor, rofecoxib, was used as a model for kampferol 
binding to COX2. Structure (2.7 Å) of COX2 and rofecoxib, determined by X-ray 
crystallography, was used for modelling the kaempferol binding to COX2. The structure of 
COX2-enzyme (5KIR) was picked from the PDB  (Orlando and Malkowski 2016). In this 
structure, rofecoxib is bound to active site of the COX2-enzyme. Kaempferol was fitted to 
active site according to ring structures of the molecules). The DeepView – Swiss-PDB-viewer 
(Swiss Institute of Bioinformatics, Lausanne, Switzerland) was used for docking and 
visualization of the structures.   
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4.2.6 Data analyses 
 
Statistical data analysis was performed with IBM SPSS Statistics 20 or GraphPad Prism 
(Version 8) software using statistically appropriate tests suitable for this kind of analysis. T-
test was used when only two groups were compared and ANOVA when four groups were 
compared. In study I, analysis of blood pressure and vascular function was conducted with 
ANOVA for repeated measurements. In studies III and IV, a general linear model for repeated 
measurements was used in the analysis of blood pressure and vascular function.  A general 
linear model for univariate analysis was used to detect group differences in clinical chemistry 
measurements in studies III and IV. P value was considered significant when p<0.05. Data 
presented is mean ± standard error of mean (SEM) unless stated otherwise. 
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5 RESULTS  
5.1 Weight gain, food and fluid consumption (Studies I-IV) 
 
At the end of the treatment period, weight gain and relative organ weights (kidney, heart 
and left ventricle) were similar in all SHR groups (Study I-III). In study IV, high-salt (HS) groups 
had approximately 12 % lower body weights probably due to the unpleasant taste of the 
food and its smaller consumption and higher relative organ weights (% per body weight) of 
the kidneys, heart and left ventricle than rats with normal diet (Table 8).  
 
Table 8. Relative organ sizes of the rats in study IV.   
 Kidney 
%/body weight 
Heart 
%/body weight 
Left ventricle 
%/body weight 
Control  0.31 ± 0.0 0.25 ± 0.0 0.21 ± 0.0 
Lingonberry 0.31 ± 0.0 0.26 ± 0.0 0.21 ± 0.0 
HS 0.41 ± 0.0*** 0.30 ± 0.0*** 0.23 ± 0.0*** 
HS + Lingonberry 0.40 ± 0.0*** 0.30 ± 0.0*** 0.24 ± 0.0*** 
***p<0.001 when compared to the control, ANOVA. 
 
No adverse effects or abnormal behavior were seen in the rats. In studies I-II, rats drank less 
water than the berry juices. In study III, no significant differences were detected. In study IV, 
slight differences were seen in the consumption of the drinking fluid. The daily drinking 
amounts of water, lingonberry, HS, HS + lingonberry were as follows:  47 ± 4.2, 33 ± 3.5, 55 
± 4.9 and 42 ± 3.5 ml, respectively. The difference was significant only between rats with the 
HS vs lingonberry groups. The average feed intake was similar in all groups (from 18 to 20 
g/d). 
 
 
5.2 Polyphenol intake (Studies I-IV) 
 
The daily intake of polyphenols per rat (mg/kg/day) is presented in Table 9. The intake of 
polyphenols was highest in the lingonberry group in studies I and II, when compared to 
cranberry and blackcurrant groups. In lingonberry juices, procyanidins were the most 
dominant polyphenol group, whereas in blackcurrant and cranberry groups, anthocyanins 
were the most abundant polyphenols.   
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Table 9. Polyphenol intake (mg/kg body weight) at treatment week 8.  
 Lingonberry 
mg/kg 
Blackcurrant 
mg/kg 
Cranberry 
mg/kg 
Lingonberry 
mg/kg 
Lingonberry 
mg/kg 
Study I, II I, II I, II III IV 
Polyphenols total 101.1 93.0 62.4 40.2 32.6a     44.6b 
Hydroxybenz. acid 0.5 0.2 0.2 0.1 0.1            0.1 
Hydroxycinn. acid 8.2 7.6 11.0 2.9 2.4            3.3 
Anthocyanins 22.3 67.0 26.3 7.0 5.6            7.7 
Flavonols 17.0 10.9 12.1 4.4 3.6            5.0 
Flavan-3-ols 17.4 0.0 1.5 3.5 2.9            3.9 
Procyanidins 35.6 7.4 11.3 22.2 17.9        24.5 
a Normal diet, b HS diet. 
 
 
5.3 Blood pressure (Studies I, III and IV) 
 
Systolic blood pressure was significantly decreased during the eight weeks’ treatment when 
compared to the control group in the older (9-17 weeks) rats (Study III) (Figure 5). The 
reduction of blood pressure was also reflected in the lower levels of mean arterial pressure 
(MAP) when compared to the control group (Figure 5). In the younger rats (6-14 weeks) 
investigated in Study I, provision of lingonberry did not ameliorate the rapid increase in blood 
pressure typically encountered in young SHR. In Study IV, blood pressure was not affected 
by lingonberry juice during the experiment.  
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Figure 5. Systolic blood pressure (SBP) and mean arterial pressure (MAP) of hypertensive rats in 
study III.** p<0.01, General linear model for repeated measurements.  
 
 
5.4 Vascular reactivity (Studies I, III and IV) 
 
In study I, the maximal acetylcholine-induced relaxation of mesenteric arteries was 75 % of 
the pre-existing contraction in the control group of SHR after the eight-week study period. 
In the lingonberry group, the response to acetylcholine was enhanced by as much as 100 % 
(Figure 6). Diclofenac (a COX inhibitor) had no effect on the extent of the relaxation, whereas 
L-NAME (NOS inhibitor) abolished the Ach-induced relaxations completely in the control SHR 
group but only partly in the lingonberry group. This residual relaxation in the presence of L-
NAME and diclofenac in the lingonberry group was almost totally abolished by apamin (small 
conductance KCa, SKCa inhibitor) and TRAM (intermediate conductance KCa, SKCa inhibitor). 
Cranberry and blackcurrant treatments did not show any significant improvements in the 
relaxation of the vessel. The endothelium-dependent relaxations from Study I are illustrated 
in Figure 6. 
In the mesenteric arteries of SHR examined in study III, no significant improvements were 
seen in the acetylcholine response after lingonberry treatment. Consumption of a high-salt 
diet did not affect the vascular response (Study IV).  
Sodium nitroprusside, a NO donor, induced an endothelium-independent relaxation which 
was enhanced in the lingonberry group when compared to the control group in Study I 
(Figure 6). In study III, endothelium-independent relaxation did not significantly differ 
between the study groups indicating that the relaxation effect of lingonberry juice on 
mesenteric arteries of SHR was endothelium-dependent. 
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Figure 6. Endothelium-dependent (Ach) and –independent (SNP) vascular responses of mesenteric 
artery rings after the eight-week treatment in study I. *p<0.05, ** p<0.01, ***p<0.001, ANOVA for 
repeated measurements.  
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5.5 Renin-angiotensin system and nitric oxide (Studies II-IV) 
 
The effects of long-term treatments on renin-angiotensin system were evaluated by RAS-markers 
from serum/plasma, kidney and aortic samples (Table 10).  
 
 
Table 10. The effects of berries on markers related to the renin-angiotensin system.  
 Study Sample/method Results 
Angiotensin II II Plasma/ELISA Lingonberry            ↓* 
Blackcurrant           ↓* 
ACE1 
 
III, IV 
II 
Plasma/ELISA 
Aorta/mRNA 
                                   ↔ 
Lingonberry            ↓* 
 Cranberry               ↓* 
ACE1 activity III Serum 
Kidney 
 
                                  ↔ 
Aldosterone III, IV Plasma/ELISA                                   ↔ 
Total NO II, III, IV Plasma/ELISA                                   ↔ 
*p<0.05, ANOVA (II, IV) or General linear model for univariate analysis (Study III). 
 
 
The concentrations of angiotensin II peptide in plasma samples were reduced by lingonberry 
and blackcurrant treatments in study II. In the same experiment, lingonberry treatment 
down-regulated ACE1 gene expression in the aorta, also cranberry treatment reduced the 
expression. Serum and kidney extracts were used to determine ACE1 activity in study III, no 
differences were observed. Furthermore, in study IV, no differences were found between 
the groups in their plasma ACE1 protein levels.  
The aldosterone level in plasma was not affected by the treatments in studies III and IV. 
Furthermore, total NO was unchanged in studies II-III.  
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5.6 Inflammation and COX2 (Studies II, III and IV) 
 
5.6.1 Clinical chemistry 
 
Clinical chemistry analyses were conducted to evaluate the effects of the treatments to the 
basic functions and electrolyte balance in rats. 
Serum alkaline phosphatase levels were reduced by lingonberry treatment in hypertensive 
rats (Figure 7). The tendency to similar direction was also seen in the normotensive WKY rats 
with or without high-salt diet. 
 
 
Figure 7. Serum alkaline phosphatase (ALP) in hypertensive (SHR) and normotensive rats (WKY) with 
or without salt loading (HS) after the eight-week treatment period. p<0.05, **p<0.01, t-test (SHR), 
General linear model for univariate analysis (WKY). 
 
Lingonberry treatment increased serum calcium and chloride concentrations when 
compared to the control group (Table 11).  
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Table 11. Clinical chemistry data of serum samples from studies III and IV.  
Study III Study IV 
  Control Lingonberry Control Lingonberry HS HS Lingonb. 
Ca       μmol/l 2.8 ± 0.0** 3.0 ± 0.1 2.8 ± 0.0 2.8 ± 0.0 2.7 ± 0.0 2.7 ± 0.1 
Cl        μmol/l 104 ± 0.4* 105 ± 0.4 105 ± 0.5 103 ± 0.5 106. ± 0.8 108 ± 0.3 
Chol   mmol/l 2.2 ± 0.1 2.4 ± 0.1 3.0 ± 0.1 2.8 ± 0.1 1.9 ± 0.1 2.0 ± 0.2 
HDL   mmol/l 0.6 ± 0.0 0.6 ± 0.0 0.8 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 
LDL    mmol/l 0.2 ± 0.0 0.2 ± 0.0 0.3 ± 0.0 0.2 ± 0.0 0.2 ± 0.0 0.2 ± 0.1 
TG     mmol/l 1.3 ± 0.1 1.1 ± 0.1 2.0 ± 0.2 2.1 ± 0.2 1.1 ± 0.1 1.1 ± 0.1 
Alb     g/l 41.7 ± 0 41.4 ± 1 38.5 ± 0 38.4 ± 0 37.5 ± 1 36.5 ± 1 
Urea  mmol/l 7.2 ± 0.3 7.3 ± 0.2 7.4 ± 0.1 6.8 ± 0.01 9.4 ± 0.12 9.4 ± 0.1 
**p<0.01, *p0.05, t-test (Study III), ANOVA for univariate analysis (Study IV). 
 
 
5.6.2 Inflammatory variables and effects of salt-loading  
 
As expected, HS diet induced a slight increase in inflammatory markers. Cyclic GMP, 8-
isoprostane and albumin levels in urine were increased (Table 12.) (Study IV). In the 
lingonberry group, levels were slightly lower, but differences were not statistically 
significant. Inflammation and kidney stress were seen in increased relative kidney, heart and 
left ventricle weights in salt-loaded rats (presented in Chapter 5.1). Interestingly, ICAM was 
lowered by consumption of a high-salt diet and even more with lingonberry treatment when 
compared to the control group. In SHR (Study III), no differences were seen in variables 
measured from urine (cyclic GMP, 8-isoprostane and albumin). 
The effects of salt-intake were seen also in increased urine concentrations of sodium and 
chloride (Table 12) and the excretion of calcium was also increased.  
 
Table 12. Inflammatory variables in the urine. Values (± SD) are set in proportion to mg creatinine. 
*p<0.05, ** p<0.01, ***p<0.001 when compared to the control group, ANOVA for univar. analysis.  
  Control Lingonberry HS HS Lingonberry 
8-isoprostane pg/mg 5.4 ± 1.1 4.4 ± 1.3 9.3 ± 2.4* 8.0 ± 2.7 
cGMP pmol/mg 0.45 ± 0.1 0.71 ± 0.3 1.58 ± 0.2** 1.68 ± 0.3** 
Albumin ng/mg 234 ± 25 346 ± 39 1216 ± 240*** 1215 ± 223*** 
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5.6.3 Gene expressions 
 
Lingonberry juice affected the gene expressions of inflammatory and atherothrombotic 
markers (Table 13). The levels of MCP1 cytokine was reduced in lingonberry group in study 
II. Relative gene expression analysis showed that there was about a 50 % reduction in MCP1 
gene expression after lingonberry treatment. The relative expression of p-selectin was also 
significantly lowered in lingonberry and cranberry groups. In addition, VCAM-1 expression 
was lower in the lingonberry group. In study IV, gene expressions of VCAM-1 and p-selectin 
did not differ between the study groups. COX2 gene expression was significantly down-
regulated by lingonberry treatment in study II. Blackcurrant juice decreased the expression, 
but the effect was less impressive than that achieved with lingonberry. In study IV, COX2 
relative gene expression was increased by about 50 % after the consumption of the HS diet 
when compared to control group. Lingonberry treatment lowered the expression in SHR to 
the same level as that observed in WKY.  
 
Table 13. Inflammatory and atherothrombotic markers. Relative gene expressions in the aorta in 
Study II.  
 COX2 MCP1 P-selectin VCAM-1 
Cranberry ↔ ↔ ↓** ↔ 
Lingonberry ↓** ↓*** ↓*** ↓*** 
Blackcurrant ↔ ↔ ↔ ↔ 
↔=ns, **<0.01, ***<0.001, ANOVA. 
 
 
5.6.4 COX2 and the kidneys (additional data)  
 
Strong signals of COX2 were seen in the macula densa area in the kidney cortex with 
immunohistochemical staining. COX2-positive macula densa area in the kidney cortex was 
significantly increased in lingonberry-treated hypertensive rats. The HS diet inhibited the 
COX2 expression in the macula densa area (Figure 8) (Study IV). The expression was highest 
in the lingonberry treated rats consuming the normal food.  
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Figure 8. Positive macula densa area in the kidney cortex of the rats. *=p<0.05, **=p<0.01, p<0.001,      
t-test (Study III) or General linear model for univariate analysis (Study IV). 
 
5.6.5 Molecular docking, COX2 
 
Differences between kaempferol orientation in complex structures bound from PDB 
(proteins pdb-code: 4det, 5aux, 2c1z, 3qwh, 4el9, 4rel, 5av2, 5av3, 1h1m ja 6m8b) is 
illustrated in Figure 9. Torsion angle between ring structures does not differ much between 
different structural orientations. 
 
 
     Figure 9. Kaempferol rotations. White is carbon, red is oxygen. 
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According to bounding model of rofecoxib, kaempferol could be bound to COX2 by four 
different orientations (Figure 10A-D). Kaempferol has the ability to similar binding as 
rofecoxib due to binding interactions and steric effects.  
 
                 
Figure 10A. Kaempferol in the active site of COX2, mod1.               Figure 10B Kaempferol in the active site of COX2, mod2. 
                  
Figure 10C. Kaempferol in the active site of COX2, mod3.               Figure 10D. Kaempferol in the active site of COX2,mod4.  
In the molecular structures in Figures 10 A-D, white is carbon (C), red is oxygen (O), nitrogen (N) 
is blue and yellow is sulphur (S).                     
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6 DISCUSSION 
 
In this series of four studies, three berries and their effects on blood pressure, vascular 
function and inflammation were investigated in experimental studies with hypertensive and 
normotensive rats. Lingonberry, cranberry and blackcurrant juices were compared in the first 
two studies and lingonberry juice was chosen for the further two studies.  
Lingonberry juice as drinking fluid was shown to enhance vascular function and reduce 
systolic blood pressure and mean arterial pressure. It was not possible to observe any dose-
dependency for these vascular effects in this series of studies. Endothelium-dependent 
vasodilatation was found to be mediated via nitric oxide (NO) and endothelium-derived 
hyperpolarizing factor (EDHF). In addition, lingonberry has displayed anti-inflammatory and 
anti-atherothrombotic effects.  
 
 
Antihypertensive effects of lingonberry  
 
The systolic blood pressure of spontaneously hypertensive rats was lower in the lingonberry 
treated rats during the eight-week study period (III). Lingonberry juice also attenuated the 
age-related elevation of the systolic blood pressure encountered in the last weeks of the 
study period. Mean arterial pressure was lower in rats treated with lingonberry juice at the 
end of the study. As far as is known, this was the first study where the blood pressure 
lowering effect of lingonberry consumption has been demonstrated in experimental animals.  
However, there are clinical studies revealing the blood pressure lowering effects of other 
polyphenol rich berries, like blueberry and cranberry  (Johnson et al. 2015; Novotny et al. 
2015) and studies conducted with berry mixes including also lingonberry  (Erlund et al. 2008). 
In the first study, where a few weeks’ younger SHR rats were used, lingonberry juice was not 
able to abolish the blood pressure increase typical for SHRs. Antihypertensive effects were 
not detected after consumption of cranberry or blackcurrant juices. Interestingly, 
consumption of a high-salt diet did not markedly increase the blood pressure of 
normotensive WKY rats and possibly therefore no significant antihypertensive effect of 
lingonberry juice was evident (IV).  
The age of the rats exerts an influence on blood pressure development and possibly on the 
effectiveness of berry treatments. The rats were three weeks younger in the first study, and 
in these young spontaneously hypertensive rats, lingonberry juice was not able to attenuate 
the strong genetically-mediated increase in blood pressure (preventive effect) (Pinto et al. 
1998). However, when the blood pressure had already stabilized at a high level, lingonberry 
juice treatment decreased the systolic blood pressure and was also able to attenuate the 
increase in the last weeks of the study, when SHRs were anticipated to display maximal SBP 
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values (over 180 mmHg). The concentration of lingonberry juices differed between the 
experiments, because of the changes in growing conditions and also different dilutions were 
used. In the third study, the effect of dose on blood pressure and vascular function were 
tested. The blood pressure lowering effect was more evident with the more diluted juice, 
containing about half of the polyphenol content when compared to the stronger juice 
administered in the first study. Quinones et al.  (2011) made a similar observation when a 
cocoa polyphenol extract was administered to SHR, i.e. the two times more concentrated 
extract did not decrease the blood pressure, in contrast to the more diluted version. Phenolic 
compounds are usually anti-oxidative, but paradoxically, they might become pro-oxidative 
and produce ROS (Castaneda-Arriaga et al. 2018). The pro-oxidative effect is dose-dependent 
and influenced by environmental conditions, e.g. pH and the presence of transition metal 
concentrations can affect the reactions. This fact can support our findings. In addition to the 
pro-oxidative theory, the different blood pressure measurement methods utilized in Studies 
I and III might, at least partly, explain this phenomenon.   
 
 
The effects on vascular function 
  
The effects of lingonberry juice on vascular function were seen when vascular responses 
were assessed after the treatment periods. In lingonberry juice-treated rats, the impaired 
endothelium-dependent relaxation typical for SHR was totally normalized. No significant 
improvement in vascular reactivity was seen in a few week older rats after eight weeks’ 
treatment. The endothelium-dependent relaxation in study I was not totally abolished by 
inhibition of either COX or NOS, indicating that in addition to NO, also EDHF contributed to 
the endothelium-dependent relaxation of lingonberry-treated rats. In smaller arteries, 
including mesenteric artery, NO-independent relaxation has a more dominant role than in 
major arteries, such as aorta  (Mulvany and Aalkjaer 1990). Experimental studies with other 
polyphenol-rich products, such as red wine, blackcurrant, berry juices  (Auger et al. 2011; 
Auger et al. 2015; Rashid et al. 2018) and resveratrol  (Li et al. 2016; Fabricio et al. 2017) 
have detected enhanced endothelium-dependent relaxations. Tabart et al.  (2018) noted 
that in commercial blackcurrant juices, the extent of the relaxation of porcine coronary 
arteries correlated with the total anthocyanin content. This could partly explain the differing 
results between studies I and III, since the higher polyphenols and anthocyanin content in 
study I apparently affected the relaxation.  
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Mechanisms of action  
 
The important blood pressure regulator, the renin-angiotensin system, was affected by berry 
treatments. Lingonberry consumption lowered the plasma level of angiotensin II, also gene 
expression of the Ang II producing enzyme ACE1 was diminished in the aorta after eight 
weeks’ treatment. Together with lingonberry, blackcurrant lowered circulating Ang II and 
cranberry lowered ACE1 gene expression in the aorta. However, no changes in circulating 
ACE1 protein were seen after berry treatments.  
Angiotensin II is a powerful vasoconstrictor  (Khanna et al. 2017) but it also acts to induce 
inflammation and is active in several other pathological states  (Montezano et al. 2014). ACE1 
inhibition in vitro has been shown previously with polyphenol-rich cocoa, tea and red wine  
(Actis-Goretta et al. 2006), also blueberries have lowered circulating ACE levels in rats  
(Wiseman et al. 2011). Apparently, at least flavanols, flavonols, flavan-3-ols and procyanidins 
have an ability to inhibit ACE1 in vitro  (Actis-Goretta et al. 2003, 2006). This is in line with 
our data from study I, where the intake of flavan-3-ols and procyanidins was highest in 
lingonberry treated rats. The lower circulating level of Ang II is in line with lowered gene 
expression of ACE1, since Ang II is formed by cleavage from angiotensinogen by ACE1. The 
inhibition of Ang II expression by resveratrol was reported in aging kidney of the mice 
together with the reduced expression of ACE1  (Jang et al. 2018). The reduced level of Ang II 
in the circulation might also be related to the inhibition of inflammation.  
The aortic relative gene expressions of COX2, MCP1, P-selectin and VCAM1 were down-
regulated after lingonberry treatment. The results of gene expression data support the 
theory that lingonberry juice has anti-inflammatory properties involving a possible role of 
the NF-kB pathway, as previously has been described for polyphenols  (Hämäläinen et al. 
2007; Rius et al. 2010). The down-regulation of p-selectin and VCAM1 is related to anti-
thrombotic actions and endothelial function  (Mozos et al. 2017). Circulating concentrations 
of VCAM1, LDL and total cholesterol levels have been shown to be lowered after 8 weeks’ 
consumption of strawberries in a clinical study with overweight subjects  (Basu et al. 2010). 
At the same time, NO has been shown to affect inflammatory processes e.g. inhibiting the 
effects of adhesion molecules and MCP1  (Takahashi et al. 1996; Ewart et al. 2008).  
The synthesis of prostaglandins and thromboxane A2 together with other prostanoids is 
mediated by COX. Overexpression and increased activity of COX2 have been shown in small 
resistance arteries of hypertensive patients impairing the availability of NO  (Virdis et al. 
2013). Thus, inhibition of COX2 expression in aorta could partly enhance the bioavailability 
of NO. In summary, these possible anti-inflammatory actions of lingonberry could be due to 
an enhancement of the production and bioavailability of NO. This is also supported by the 
finding of endothelium-dependent relaxation, which was partly mediated by NO. Previously, 
endothelial NO production was found to be enhanced by consumption of a polyphenol-rich 
diet in subjects with a high cardiovascular risk  (Medina-Remon et al. 2015).  
Serum alkaline phosphatase was markedly reduced by lingonberry treatments in studies III 
and IV. Circulating ALP is considered to be an independent and strong predictor of all-cause 
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mortality in patients with chronic kidney disease as well as in the general population  
(Haarhaus et al. 2017). Serum ALP activity has been associated with CRP and inflammation  
(Nayeem et al. 2010; Damera et al. 2011; Seo et al. 2019). Interestingly, endothelial 
dysfunction  (Perticone et al. 2015) and the phenomenon of a slow coronary flow  (Wang et 
al. 2018) also seem to be related to the increased ALP levels.  
Interestingly, the expression of COX2 protein in the macula densa area of the kidneys was 
significantly increased in lingonberry juice-treated hypertensive rats and a minor increase 
was seen also in normotensive rats. In contrast, the high-salt diet almost completely 
abolished the expression. As discussed earlier, COX2 has a dual role and especially in the 
kidneys, it is constitutively expressed and contributes to the regulation of blood flow. In the 
kidneys, COX2 is regulated by Ang II and AT1 and AT2 receptors  (Zhang et al. 2006). In cortex 
and macula densa, COX2 mediates sodium balance and the regulation of renin release  
(Harris and Breyer 2001). Two RAS components, Ang II and aldosterone, decrease COX2 
expression in the macula densa area  (Cheng et al. 1999) and Wolf et al.  (1999) revealed that 
the inhibition of Ang II upregulated COX2 expression in the macula densa and the effect is 
mediated via AT1 receptors. The COX2 expression in macula densa is increased during salt 
deprivation  (Harris et al. 1994). Cheng et al.  (2000) found that in addition to low-salt, 
captopril, an ACE1 inhibitor, strongly induced COX2 expression in Sprague-Dawley rats. 
When compared to previous results, the increased expression of COX2 protein in macula 
densa by lingonberry could be a reflection of inhibition of RAS, especially ACE1. As far as is 
known, this is the first time when polyphenol-rich foods have been shown to increase COX2 
expression in the macula densa area.   
A high-salt diet impaired the kidney function of young rats, whereas blood pressure or 
vascular function were not affected. The increased sizes of the kidneys, heart and left 
ventricle together with increased urinary albumin, cGMP and 8-isoprostane can be regarded 
as reflections of the presence of the oxidative stress induced by high-salt diet.   
 
 
Polyphenols in action and safety issues 
 
The effects of polyphenols are apparently dependent on the type and dose of the 
polyphenol(s) being administered. Some plateau- or saturation point seems to exist. For 
instance, acute flow-mediated dilatation (FMD) was enhanced dose-dependently by 
procyanidins until a dose of 0.5 g/d; with catechol flavonoids, the corresponding amount was 
0.2 mg/d  (Kay et al. 2012). Metabolism is affected by dietary factors and it seems to be that 
too high a dose might decrease the bioavailability, as has been seen with chlorogenic acid  
(Stalmach et al. 2014). A critical point in polyphenol or berry studies is to provide a suitable 
control product. The actions of polyphenols are affected by their chemical nature and 
bioavailability, which differs greatly between phenolic compounds. As discussed earlier, the 
bioavailability is a result of several mechanisms which are affected by the food matrix, 
intestinal microbes and other factors. The health-promoting effects are partly due to the 
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polyphenols themselves and partly due to their metabolites. Polyphenols are secondary 
metabolites of the plants, their concentration is affected by growing conditions, such as UV-
light, dryness and pathogens. Thus, the polyphenolic content may vary between growing site 
and years due to different growing circumstances  (Bujor et al. 2018). In addition to the 
concentration differences in our studies, there were slight differences in the polyphenolic 
composition of the juices. The more diluted juice contained a relatively higher amount of 
procyanidins, but the intake of procyanidins was higher from the more concentrated juice. 
There might also be some undetected differences in the polyphenolic compositions of the 
juices, due to different growing places and harvesting years. We were not able to detect 
these kinds of differences with the methods available.  
 
In the molecular docking model, we showed that the kaempherol structure could 
theoretically bind and act as inhibitor of COX2. Kaempherol was modelled to active site of 
COX2 using rofecoxib, a selective non-steroidal anti-inflammatory drug, as a template. 
Lingonberry contains several different kaempherols (Bujor et al. 2018). Since the torsion 
angle changes of different kaempherols did not differ to any great extent, several potential 
inhibitor structures are possible.  
 
Berries are considered as safe to use. Caution is needed only when pure polyphenols are 
used. Pure polyphenols or high amounts of polyphenol-rich foods can interact with some 
medicines metabolized through CYP-family  (Basheer and Kerem 2015). In those cases, the 
effect of the drug can be either inhibited or enhanced. In this series of experiments, relatively 
high amounts of polyphenols were ingested in berry drinks. No adverse effects were found. 
The accepted daily intake for lingonberry polyphenols is not established. The EFSA has stated 
that as a food ingredient, anthocyanin can be used with a quantum satis principle. The LD50 
value has been determined for an extract containing cyanidin, petunidin and delphinidin, for 
mice, the LD50 value was 25 g/kg; for rats, it was 20 g/kg  (Wallace and Giusti 2015). In a 
review of anthocyanin RCTs, no adverse effects were reported after the consumption of 
anthocyanin concentrations up to 0.640 g/day  (Wallace et al. 2016).    
 
 
Methodological aspects  
 
Spontaneously hypertensive rats are a widely used model for hypertension. Their systolic 
blood pressure increases to over 200 mmHg within a few months (3-4) after birth  (Okamoto 
and Aoki 1963). Wistar Kyoto rats are the normotensive reference strain for SHR. In our last 
study, we wanted to increase the blood pressure by high-salt diet in order to reflect 
nutritional aspects behind the increase in blood pressure. Blood pressure did not increase 
during our 10 weeks’ treatment, probably due to the fact that the salt exposure was too 
short and mineralocorticoid treatment was not added. However, we were able to observe 
other effects caused by high-salt diet. 
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Lingonberry juice was too astringent for rats and therefore sucrose was added to make it 
more palatable for the animals. Sucrose was added to the control animals´ drinking water in 
studies III and IV to avoid bias. Lingonberry treatment did not affect the weight gain of the 
rats (Studies I and III). Normotensive WKY rats consuming a high-salt diet were lighter than 
WKYs without salt.  
Blood pressure was measured by the tail-cuff method, which is a widely used and well-known 
non-invasive method used in experimental studies. At first, rats were acquainted with the 
measuring technique, and they readily adapted to the procedure. The blood pressure 
assessments were made by the same researcher at the same time of day to minimize errors 
in the measurements. In study I, an older measurement device (Apollo) was used to monitor 
the signal from the cuff, whereas in Studies III and IV, newer equipment (CODA) was 
available. The measurement of blood pressure was more reliable and possibly more accurate 
with CODA, since more measurements could be made, and also diastolic blood pressure was 
more stable. In Study III, we also had the opportunity to use a more modern and quiet 
examination room for our blood pressure measurements, which possibly may have been less 
stressful to the animals. This might partly explain the differences in the effects on blood 
pressure. 
Vascular responses were studied in an organ-bath chamber with an isolated superior 
mesenteric artery (resistant artery) of the rats. Mesenteric arteries were suitable for 
detecting vascular resistance and hypertension. Aortic sections were used for mRNA studies. 
Due to practical problems, resting tensions were adjusted to different levels in the studies. 
For example, a higher resting tension was more appropriate for larger rats and tension 
remained throughout the rather prolonged test period. Baseline resting tension was reduced 
from the force of contraction in order to balance the differences between samples. However, 
this might have a slight influence on the divergent results found in the different studies.  
 
 
Clinical relevance and future prospects  
 
Nutrition plays a major role in the prevention and treatment of hypertension and 
cardiovascular disease. Lifestyle guidance is recommended in Finnish Current Care 
Guidelines of Hypertension (2014). It is evident that even minor reductions in systolic and 
diastolic blood pressure can decrease an individual’s risk of stroke, heart failure and coronary 
artery disease. It is possible to achieve a moderate reduction of blood pressure by consuming 
polyphenol-rich foods. Especially, in the Nordic countries, wild berries are the best source of 
bioactive polyphenols.  
Results from these experimental studies cannot be extrapolated directly to clinical situations 
in humans. However, important pre-clinical mechanistical information and indication of 
actions were obtained and the results can be utilized in clinical trials. 
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These actions are related to the polyphenolic profile of the berry. In our study, cranberry 
juice did not affect vascular function, but there are some clinical indications for possible anti-
inflammatory and anti-infective actions of cranberry, especially in conjunction with urinary 
tract infections  (Foxman et al. 2015; Mantzorou and Giaginis 2018). Clinical studies with 
lingonberries will be needed to clarify its benefits for human health. Nevertheless, some of 
our preclinical results as well as the work of others are encouraging, i.e. lingonberry may be 
able to improve vascular function and to exert positive effects on cardiovascular health 
including inflammation and oxidative stress.  
ACE1 inhibitors are primary drugs for the treatment of hypertension  (Williams et al. 2018). 
In the USA, the classification and the recommendations for lowering the blood pressure are 
being re-evaluated  (Whelton et al. 2018). This would be expected to cause an increased 
need for the use of medication. In cases of mild hypertension, ACE1 inhibiting polyphenol-
rich foods and supplements could be used as a non-medical treatment with less adverse 
effects than pharmacological agents, or perhaps as a sensitizer of drug treatment. The dual 
role of COX (inducible and constitutive) leads to the fact that NSAIDs possess adverse effects 
especially on renal balance  (Curtis et al. 2019). As was shown in this thesis, lingonberry is 
able to inhibit vascular, probably inducible, COX2 while still maintaining the expression of 
constitutive COX2 in the kidneys. This phenomenon should be investigated further and 
utilized as a safer treatment for inflammatory states.  
 
 
 
This series of studies revealed that lingonberry juice has the potential to decrease blood 
pressure and improve vascular function in experimental models. However, possible dose 
dependency needs further clarification. The inhibition of the renin-angiotensin system, 
especially ACE1 inhibition and thus the ability to prevent the detrimental effects of 
angiotensin II together with enhancing NO bioavailability are potential mechanisms 
accounting for these positive vascular effects. These effects seem to be dependent on the 
concentration and the polyphenolic profile of the berries. Lingonberry juice treatment exerted 
anti-inflammatory actions, which most likely contributed to the improved vascular function. 
The property of lingonberry juice to inhibit inducible COX2 in vasculature together with the 
preservation of important constitutive renal COX2 are promising, but these putative 
mechanisms need to be confirmed with more detailed experimental evidence and clinical 
approval.   
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7 SUMMARY AND CONCLUSIONS 
 
In this series of four studies, we investigated the effects of three berries, lingonberry, 
cranberry and blackcurrant on blood pressure and vascular function in experimental models 
of hypertension. A special focus was placed on lingonberry and its effects on the renin-
angiotensin system, its anti-inflammatory actions; the role of COX2 was also evaluated. Here 
are the main findings emerging from this series of studies: 
 
? Consumption of lingonberry juice lowered the already elevated blood pressure of 
spontaneously hypertensive rats.  Lingonberry juice was not able to prevent the 
development of genetic hypertension in these rats and no dose-dependency was 
observed. 
 
? The impaired endothelium-dependent relaxation of SHRs was normalized after 
lingonberry juice consumption in younger rats with a high dose, but no enhancement 
was seen in older rats receiving a lower dose. The higher dose of lingonberry juice 
also ameliorated endothelium-independent relaxation of mesenteric arteries. 
 
? Lingonberry juice might reduce the extent of inflammation related to hypertension 
and vascular dysfunction. Its anti-inflammatory mechanism seems to be related to 
inhibition of certain proteins and peptides (COX2, Ang II, MCP1) and 
atherothrombotic (MCP1, p-selectin, VCAM) markers. The reduction of the 
circulating levels of alkaline phosphatase might also have a positive effect on 
endothelial function and vascular health.  
 
? The blood pressure lowering effects of lingonberry juice are possibly related to the 
renin-angiotensin system i.e. its partial inhibition. Circulating levels of Ang II were 
reduced in plasma and the aortic gene expression of ACE1 was down-regulated. 
Lingonberry juice treatment increased the expression of COX2 in the macula densa, 
which also might contribute to the inhibition of RAS. 
 
? A moderate abolishment of inflammation and renal damage induced by a high-salt 
diet and possible anti-inflammatory effects were seen, but more definitive 
conclusions will need further studies.   
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